Prince Faisal bin Bandar Al Saud, prior to being appointed as the Governor of Riyadh Province, served as Deputy Governor of Asir Province and Governor of Al-Qassim Province.
Prince Faisal obtained a bachelor of arts degree in history at King Saud University.
In February 2013, Saudi Arabia’s King Abdullah Bin Abdulaziz Al Saud issued a Royal Order to appoint Mr. Mohammed Al-Sheikh as the Chairman of the Board - Capital Market Authority of Saudi Arabia.
Prior to his appointment as the CMA’s Chairman of the Board, Mr. Al-Sheikh had been serving as the Executive Director, Member of the Boards of Directors of the World Bank Group; representing the Kingdom of Saudi Arabia.
Mr. Al-Sheikh is an experienced transactional lawyer, and is a former partner at a number of international law firms most recently Latham & Watkins LLP, whose practices focused on capital markets, mergers and acquisitions, project finance, restructuring, banking, general finance matters and Islamic finance.
Mr. Al-Sheikh has nearly two decades of experience representing sovereign wealth funds, government bodies, banks and other businesses located or operating in Saudi Arabia and the Gulf Region. Mr. Al-Sheikh has also acted as a Board Member in a number of public and private companies in various industries.
As a recognized leader in Islamic finance, Mr. Al-Sheikh has published and lectured extensively on Sharia-compliant banking and finance law.
Mr. Al-Sheikh holds an LLM from Harvard Law School and a B.A from Umm Al-Qura
University. April 10, 2015 The Custodian of the Two Holy Mosques, King Salman
bin Abdulaziz Al Saud, issued a Royal Decree appointing His Excellency the
Minister of State and the Member of the Council of Ministers Mr. Muhammad bin
Abdul Malik bin Abdullah Al-Ash Shaikh as the Acting Minister of Health.
He received his Bachelors Degree in Medicine & Surgery with 2nd degree honors
from the Medical College King Saud University, Riyadh and finished his
internship in 1978.
In 1995 he became a Fellow of the American College of Surgeons.
In 2000 he was appointed as Deputy Minister of Health for Executive Affairs; he was Chairman of the Rift Valley Fever committee and some of the Hajj Pilgrims committees. He was Chairman of the Board of Directors for two of the largest hospitals in the Kingdom and headed international Saudi delegations. He is a member of numerous councils including the Saudi Commission for Health Specialties and the Saudi Council for Health Services. In 2004 he was appointed by a Royal Decree as the Deputy Chief Executive Director of the King Faisal Specialist Hospital & Research Center in Riyadh and in 2005 he was appointed as Chief Executive Director of the King Faisal Specialist Hospital & Research Center and General Secretary and Member of the Board of Directors.
In 2009 he was promoted by a Royal Decree as the Chief Executive Officer at King Faisal Specialist Hospital & Research Center with excellency ranking which he has occupied until the present time.
He has a number of publications in the area of laparoscopic surgery and trauma as well as being a reviewer and member of the Editorial Board for a number of medical journals. He has been active in the area of academic medicine as a teacher and program director. His administrative experience ranges from governmental policy-making to practicing academic medicine as a Consultant and Senior Physician.
He is a member of numerous governmental committees in the healthcare sector, some of which are ministerial committees that steers health strategies and service formulation.
Currently he oversees specialized hospital practice and services as well as advanced research activities relating to basic as well as translational research and also the formulation of a biotechnology platform in Saudi Arabia. He also oversees academic training programs both at the undergraduate and graduate level and is a member of the Al Faisal University Board of Trustees. He is also a member of the Board of Directors of Prince Salman Centre for Disability Research.
Dr. Al-Mazrou gained his medical degree from Mosul Medical College in Iraq in 1971 and in 1977 he received a diploma in child health from the Royal College of Physicians and Surgeons in Ireland. In 1992, he obtained a PhD from City University in London, UK.
Dr. Al-Mazrou has been working in the immunization field for 27 years. He started his career as a Director General for Primary Health care in the implementation of the Expanded Programme of Immunization in the 1980s in Saudi Arabia. He then became the Assistant Deputy Minister for Preventive Medicine at the Ministry of Health, Saudi Arabia, and has focused on eradication activities of vaccine preventable diseases.
He has been member of the Regional Commission for Certification of Polio Eradication since its formation in 1995, in addition to his membership of the Advisory Committee of the Horn of Africa. In the past decade, he was the Chair of Technical Advisory Group on polio eradication for Yemen and Egypt. From 2001-2004, he served as a member of the WHO Executive Board, and from 2004-2010, he was a member of the Advisory Committee for polio eradication for WHO.
Dr. Al-Mazrou's research interests include prevention of vaccine preventable diseases, particularly polio, in children of the Middle East region. In 1988, he was awarded the "Jacques Parisot" Prize for research in primary health care and public health by WHO; and in 1990, he was awarded the "Universal Child Immunization Commemorative Medal" by UNICEF, in recognition of his efforts in contributing to universal child immunization. Doctor Al-Mazrou is the author of over 90 publications and over 20 book chapters and reports.
Dr. Bin Saeed is the Deputy Minister of Health, Public Health in the Ministry of Health of the KSA. He is a public health physician with extensive experience
in epidemiology, operations research and teaching. Dr Bin Saeed earned his PhD in epidemiology from the University of Texas in 2002, and served as chairman of
the department of family and community medicine, college of medicine at the King Saud University until he was appointed as an advisor to the Minister of Health
in May 2014. In October 2014 Dr Bin Saeed was named the Deputy Minister for Public Health.
Since January 2015, Dr Bin Saeed has been leading a national effort as the commander of the Command and Control Center (CCC), a dynamic body designed to proactively combat the Corona virus and other public health threats throughout the Kingdom, including both communicable and non-communicable diseases. Dr Bin Saeed has numerous publications in the domain of public health and preventive medicine.
Ambassador Westphal was sworn in as the U.S. Ambassador to the Kingdom of Saudi Arabia on March 26, 2014.
Prior to this appointment, Ambassador Westphal was the Under Secretary of the Army and its Chief Management Officer from 2009 to 2014. In that capacity, Secretary Westphal managed a force of more than one million soldiers and several hundred thousand civilians. He also held the positions of Assistant Secretary of the Army in the Clinton Administration and Acting Secretary of the Army in the Bush Administration.
Ambassador Westphal's career spans more than 40 years of service in higher education and government. He has taught at Oklahoma State University, Georgetown University and the University of Maine where he was also Chancellor of the University System.
In government, he worked in both the House and Senate for more than twelve years. He held positions in the administrations of Presidents Carter, Reagan, Clinton, Bush, and Obama, working in the Environmental Protection Agency, U.S. Army Corps of Engineers, the Department of the Interior, and the Department of Defense.
Ambassador Westphal and his wife have four children and six grandchildren.
Ambassador Jimmy Kolker is the Assistant Secretary for Global Affairs at the U.S. Department of Health and Human Services. The Office of Global Affairs, in the Office of the Secretary, leads the Department's efforts to better the health and well-being of Americans and of the world's population through global strategies and partnerships and working with other U.S. government agencies in the coordination of global health policy. Now the Department's senior health diplomat,Ambassador Kolker previously served as the Principal Deputy Assistant Secretary of the office (2011-2014).
Prior to joining HHS, Ambassador Kolker was Chief of the HIV and AIDS Section at UNICEF's New York headquarters (2007-2011). He had a 30 year diplomatic career with the U.S. State Department where he served as Deputy Global AIDS Coordinator in the Office of the U.S. Global AIDS Coordinator (2005-2007) and U.S. Ambassador to Uganda (2002-2005) and to Burkina Faso (1999-2002). He was Deputy Chief of Mission at U.S. embassies in Denmark and Botswana and won awards for political reporting at earlier posts in the UK, Sweden, Zimbabwe, and Mozambique.
Ambassador Kolker grew up in St. Louis, Missouri. He holds a B.A. in Political Science from Carleton College (Minnesota) and a Masters in Public Administration from Harvard University. He speaks French,Swedish, and Portuguese.
Dr. Al Hazzaa is a Consultant of Ophthalmology since 1993 at King Faisal Specialist Hospital & Research Center and Head of Ophthalmology since 1997 (first Saudi female doctor to hold this position), & Acting Chairman of Ophthalmology since 2012. Forbes International Magazine chose Dr. Al Hazzaa as one of "The Most Powerful Arab Women for year 2005" & was again chosen as the "Arab Woman for year 2006."
Dr. Al-Hazzaa was appointed by King Abdullah of Saudi Arabia in January 11, 2013, among 30 women as a member to the Majlis Alshura (Saudi Parliament) in a historical move, allowing women for the first time to be part of the kingdom's formal advisory body. Dr Al Hazzaa became a Professor, College of Medicine, Al-Faisal University in 2011 (first female doctor). She is also a Senior Clinical Scientist in the Research Centre since 2008 and a Consultant in Genetics in the Research Center since 2009, at King Faisal Specialist Hospital & Research Center.
Dr. Al Hazzaa was an Associate Professor of Ophthalmology at the Wilmer Ophthalmological Institute, the Johns Hopkins University School of Medicine, Baltimore, MD., U.S.A., since 2003 & was reappointed in 2006-2009 (first Saudi Female Doctor from Middle East). In January 2007, Dr. Al Hazzaa was appointed as Senior Advisor to Minister of Health, Riyadh, Saudi Arabia.
In 1995, Dr. Al Hazzaa was "The First Saudi Female Doctor" appointed to the Medical Advisory Council, the strongest governing body of King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia. She was also the first female doctor to join as a member of the Executive Board of the Saudi Ophthalmologic Society (SOS) in 1996. In 1997, she was nominated Chairperson of Continuing Medical Education at SOS (the first female doctor). During this tenure, Dr. Al Hazzaa was Chairperson (again, the first female doctor) of Saudi Ophthalmology in 1999, 2000, & 2001.
Dr. Al Hazzaa became a member of the Editorial Board of the Saudi Journal of Ophthalmology in 1997, & then became the Associate Editor in 1998-2008 (the first female doctor). She was also a member of the Editorial Board of the prestigious Ophthalmic Genetics Journal in the USA in 1997-2005. Prior to that, Dr. Al Hazzaa was the Assistant Editor of the Middle East Journal of Ophthalmology from 1992-1996 (first female doctor). Additionally, Dr. Al Hazzaa is on the Editorial Board of the Archives of Ophthalmology, since 2005, & the Chinese Journal of Ophthalmology since 2006 representing the Middle East (first Saudi Female from Middle East).
Dr. Al Hazzaa was an Executive Board Member of the Middle East African Council of Ophthalmology, representing Saudi Arabia (1999-2005). In addition, Dr. Al Hazzaa was a member of the Ministry of Health Central Committee in Riyadh (2001) & International Faculty in the International Ocular Inflammation Society, representing the Middle East (2002). She was also the President of the Woman Promotion Forum at Prince Salman Disability & Research Center in Riyadh (2002-2004); and a member of the Global Diabetic Retinopathy Task Force in the U.S.A. representing the Middle East (2002).
Dr. Al Hazzaa was elected as an Executive Member of the International Council of Ophthalmology (ICO), the highest rank in ophthalmology worldwide, being the youngest member; the first female from the Middle East, and the only female ophthalmologist from the 5 continents in 2002-2006 and reappointed in 2006-2010.
Dr. Al-Hazzaa is a Fellow of the Royal College of Surgeons (FRCS) in Edinburgh, England (1996) and a Fellow of Johns Hopkins Medical Institutions, U.S.A. (1993). Dr. Al Hazzaa has completed a two-year Fellowship in "Retina Vascular Center," "Hereditary Eye Center" and "Eye Pathology Laboratory" at the Wilmer Ophthalmologic Institute at the Johns Hopkins University School of Medicine, U.S.A. (1990-1993). She has also completed a one-year Fellowship at the Armed Forces Institute of Pathology, Walter Reed, in Washington DC, U.S.A. (1989-1990).
Dr. Al-Hazzaa was the first Saudi doctor to receive the Best Research Award of the SOS in 1986, on "Corneal Ulcers after PKP" as the first research on PKP, and again in 1995 on "Ocular Sickle Cell Disease," where the disease was categorized for the first time. Dr. Al Hazzaa was chosen as a Resident of the Year at KKESH (1986). She also received numerous recognition awards from KFSHRC as well as various & numerous institutes in the Arab country.
Locally, Dr. Al Hazzaa received the prestigious Gold Medal Award of the SOS from HRH Prince Abdulaziz Bin Ahmed Al-Saud, President of the SOS in 1999 (first Saudi female). Dr. Al Hazzaa also received an award from Oom Al-Gura University for her medical, scientific, & humanitarian efforts in Saudi Arabia in year 2000. Dr. Al Hazzaa was named "Arab Woman of the Year" in the field of Medicine & Community Services in 2005 from the Arab Women Studies Center in Paris, France.
Dr. Al Hazzaa was "Honorary Guest Speaker" at the King Abdulaziz Center for Gifted in 2007, the "Honorary Guest" at the Janadriya Heritage Annual Festival in 2007; awarded Sheikh Abdulmagsood Khoja award in 2008 and Al-Muftah award for scientific contribution by HRH P. Faisal bin Khalid in 2009 & 2010. Dr. Al Hazzaa was the first "Guest of Honor" for Cultural Attaché in United Arab Emirates for 1st Creative Forum for Saudi Students in the UAE Universities in 2010. Dr. Al Hazzaa was the "Honorary Guest" at "Empowering Woman," Saudi Women of Tomorrow Forum, Orbit of Development for Empowerment Consultants (ODEC), in Jeddah in 2011. Dr. A Hazzaa was also a Guest speaker in the 29th Graduating Class of 2011, "Striving for a Better Future," in Jeddah.
Dr. Al Hazzaa was an invited Guest Speaker in the International Forum on Women in Science & Technology in Muslim Countries held in Kuala Lumpur, Malaysia in 2011 (first & only Saudi female). In addition, Dr. Al Hazzaa was a Guest Speaker in "PROBE Forum on Women in Increasing Women's Interest in & Participation in Politics/Public Policy" South Carolina, USA, in 2011. Dr. Al Hazzaa was also a Guest Speaker in "US Saudi Business Opportunities Forum," Atlanta, USA, in 2011.
As for medical breakthrough, in 1993 Dr. Al Hazzaa introduced the Protocol for "Retinopathy of Prematurity" & adopted according to the Johns Hopkins Medical Institution's standard. In 1994, Dr. Al Hazzaa was the first to treat "Retinopathy of Prematurity" using the "Diode Laser" in the Middle East. In 1995 the first Multi-Wavelength Laser was purchased to treat diabetic retinopathy in the Middle East by Dr. Al Hazzaa. In 1997, the first Intravitreal Ganciclovir Implant (Vitrasert) for AIDS patients was performed by Dr. Al Hazzaa in the Middle East. Dr. Al Hazzaa was the Attending Physician to His late Majesty King Fahad bin Abdulaziz, Custodian of the Two Holy Mosques from 1999 - 2000. In 2000, Dr. Al Hazzaa was the first to use Photodynamic Therapy to treat "Age Related Macular Degeneration" (ARMD) in the Gulf Region.
Dr. Al Hazzaa has organized numerous seminars on eye diseases nationally & internationally and is a professional member of 16 international & national ophthalmic societies. She is an Executive Board Member of the Saudi Committee for the Development of International Trade (CIT), of the Council of the Saudi Chamber of Commerce & Industry since 2001 and was the Executive Chair of "Friends of Saudi Arabia" in 2004-2007 lecturing in various cities in the USA, Europe, & Middle East, bridging and promoting the image & relationships of Saudi Arabia internationally.
Currently, an executive member of Saudi British Council 2012, Dr. Al Hazzaa was an official advisor to the Majlis Al Shura (Consultative Council) in 2002 & was the key factor in Majlis Al Shura Joining the Parliament in 2003.
Dr. Al Hazzaa has published 63 international papers, including 7 book chapters; the most important in Duane's International Ophthalmology, on "Genetic Eye Diseases in Saudi Arabia" (first ophthalmologist), and concluded 7 book reviews. She attended 241 symposia & presented 383 lectures in the USA, Europe & Middle East and was an invited international guest speaker in 65 lectures and an invited local speaker in 65 lectures. Dr. Al Hazzaa is currently undergoing 9 research projects and has had over 367 international & national television, radio & newspaper interviews.
Dr. Al Hazzaa was born in Riyadh, Saudi Arabia, married to Mr. Abdulla Al Obaidalla, Executive Director of University Certificates Equivalency Ministry of Higher Education with 3 children.
Mr. Hassan Al-Damluji is an expert in international development,education reform and organizational strategy. As Head of Middle East Relations at the Bill &
Melinda Gates Foundation he is responsible for the foundation's Middle East strategy across program areas, as well as acting as lead Middle East adviser to Bill and Melinda Gates.
Examples of work within the Middle East portfolio include creating alarge development financing facility in collaboration with the Islamic Development Bank, agriculture research to improve food security across the Arab World and Polio eradication in several countries, in partnership with Gulf donors.
Prior to joining the foundation, Mr. Al-Damluji designed and implemented large scale transformations for governments and philanthropy in the Middle East and the UK, both as a manager in McKinsey & Company and through establishing and leading non-profit organizations. Examples of his work include radically upgrading the school system in Pakistan,building a new vocational education system for Saudi Arabia and designing a national job creation strategy for Yemen.
In the UK, as COO and Head of Strategy at New Schools Network, Mr. Al-Damluji played a key role in the introduction of Free Schools (equivalent to Charter Schools in the US), as well as in improving the provision of disability education as COO of the national school support network,Achievement for All. He is also an adviser to a number of non-profit institutions, including Achievement for All, Injaz, the Education for Employment Foundation and Al Fanar, and is currently in the process of establishing a Free School to serve deprived children in North West London. The One Degree Academy has been approved by the UK government for opening in 2016.
Mr. Al-Damluji earned his BA in Classics and Arabic from the University of Oxford and his MA in Middle Eastern Studies from Harvard University.
Dr. Chris Karp, Deputy Director of the foundation’s Global Health Discovery & Translational Sciences program, leads the Vaccines &
Host-Pathogen Biology team that targets fundamental scientific and technological advances in global health that could lead to new ways to
prevent and treat disease.
An immunologist, infectious diseases specialist and internist, Dr. Karp joined the foundation in 2012. Prior to the foundation, he was on the faculty of the Departments of Medicine and Molecular Microbiology & Immunology at Johns Hopkins University School of Medicine, and founded the Division of Molecular Immunology at Cincinnati Children's Hospital Research Foundation, where he was Esiason/Bell Professor of Pediatrics. His academic scientific career focused on defining the mechanisms underlying the regulation and dysregulation of inflammatory responses in infectious, allergic and genetic diseases, with a focus on diseases of children.
Dr. Karp received an undergraduate degree (summa cum laude, with high honors in philosophy) from Brandeis University and an M.D. from the University of North Carolina School of Medicine, where he was a Morehead Fellow. He trained in Medicine at Brown University and Georgetown University, and then was an NRSA fellow in the Laboratory of Parasitic Diseases at NIAID, and an infectious diseases fellow at Johns Hopkins.
Dr. Peter Khoury is Senior Program Officer, Life Science Partnerships, Global Health Program, Office of the President, for the Bill & Melinda Gates Foundation. In this capacity, he assists the implementation of the Foundation's Global Health and Development strategies through supporting global programs and functional team's in identifying and pursuing important opportunities with industry partners. Dr. Khoury's specific focus is Developing Country Manufacturers (DCMs) with biopharmaceutical expertise in vaccines,drugs, medical diagnostics and devices, and biologics.
Prior to joining the Gates Foundation, Dr. Khoury was Global Vice President for Baxter Vaccines. He has worked a combined 20 years in commercial positions within both Merck and Company, Inc. and Baxter International. His responsibilities have included business development, product and promotion management, sales, domestic and international marketing, government contracting and strategy development. He has been a key member of the global launch teams for various pediatric and adult vaccine products.
Dr. Khoury obtained his doctorate in Microbiology from Syracuse University in 1991, studying the effects of heat shock proteins on the resistance of bacterial endospores. Dr. Khoury also holds a MBA from Cornell University's Johnson Graduate School of Management in marketing and general management.
Dr. Ibrahim Zaid Bin-Hussain, MBBS, ABCP, FAAP is a Consultant in Pediatric Infectious Diseases and Chairman in the Department of Pediatrics at King Faisal Specialist Hospital and Research Center in RiyadhSaudi Arabia. He is also a Consultant in Clinical Mycology in the Department of Pathology and Laboratory Medicine.
Dr. Bin-Hussain obtained his medical degree at King Saud University, Riyadh, Saudi Arabia. He received his training in pediatrics at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia and University of Tennessee - Memphis Le Bonheur Children’s Medical Center, Memphis, Tennessee, USA. He specialized in pediatric infectious diseases where he completed his fellowship programs at St.Jude Children’s Research Hospital, University of Tennessee - Memphis and Le Bonheur Children’s Medical Center, Tennessee, USA. He also attended further training in the Division of Infectious Diseases, Mycology Unit and Immune Compromised Host section, Pediatric Branch of National Cancer Institute, National Institute of Health, Bethesda, Maryland, USA. Subsequently, he obtained board certification in pediatrics (1996) and infectious diseases (1997) from the American Board of Pediatrics. In December 2013, he earned his Master Degree in Business Management for Physician Executive at the University of Tennessee, Knoxville, USA.
Dr. Bin-Hussain belongs to several national and international societies. He is the founder and Vice-President of the Board of Directors of the Saudi Pediatric Infectious Diseases Society (2009), Chairman of the Scientific Board of Pediatrics, Saudi Commission for Health Specialties (2011), Co-Chairman, Pediatric International Collaborations Office (2010), Founder (2013) and Associate Editor (2015), International Journal of Pediatric and Adolescent Medicine and member of several hospital and national committees and working group for academic and clinical activities.
Dr. Bin-Hussain delivered more than one hundred presentations in national and international conferences. In June 2012, he was invited to present the Middle East’s perspective in Invasive Mycosis in Children in the 18th Congress of the International Society for Human and Animal Mycology at Berlin, Germany. He initiated the establishment of the International Journal in Pediatric and Adolescent Medicine which was launched its first issue on January 2014. He wrote several chapters for the textbook Clinical Pediatrics, published in 1998 and the recent second edition published by Springer in 2012.He has authored more than twenty five publications in peer-reviewed journals in the field of pediatric infectious diseases and mycology.
Mr. Stephen Nash is the co-leader of the Squire Patton Boggs Healthcare Practice Group. He has represented health care organizations
for more than 30 years. His clients include academic medical centers,hospitals and health systems, health information exchanges, medical
groups and other physician organizations, health plans and other managed care organizations, long term care organizations, ancillary health
service providers, health care investors, state agencies and sovereign powers.
Mr. Nash counsels these organizations regarding governance, corporate,reimbursement, tax, privacy and security, fraud and abuse, and other regulatory compliance issues. These issues typically arise within the context of mergers, acquisitions, joint ventures, corporate reorganizations, complex contractual arrangements and other affiliations and collaborative efforts, as well as in connection with tax-exempt revenue and refunding bond issues.
Recently, Mr. Nash has had the privilege of counseling various domestic and foreign government agencies on such diverse matters as supplemental payment protocols, the design of primary healthcare systems, privacy and security issues, and regulatory requirements for health insurance.
In addition to his transactional and regulatory work, Mr. Nash has over 20 years of experience representing hospitals in single provider and group appeals for Medicare and Medicaid reimbursement, and serves as a strategic advisor on Medicare, Medicaid and private payer matters such as coverage issues and payment methods.
Mr. Nash also has substantial experience representing health information exchanges, including CORHIO, Colorado's statewide health information exchange, which he has advised, since its inception, regarding planning,organization, governance, tax-exemption, financing, contracting, and privacy and security matters. Mr. Nash also represents CIVHC, the administrator of Colorado's state-wide all-payer claims database, or APCD.
Mr. Nash speaks and publishes regularly on topics related to health care law, health information exchanges, corporate governance, clinical integration, collaborative health care ventures and the legal trends influencing the U.S. and foreign health care systems. Mr. Nash earned his B.S, M.B.A. and J.D. from the University of Pittsburg.
Dr. Tim Wilson is a general practitioner. In 1995, he became the youngest fellow of the Royal College of General Practitioners. His practice was one of
the first to receive a Charter Mark from the Cabinet Office. In 200o and 2001, Dr. Wilson was a Harkness Fellow working with Don Berwick and Paul Cleary to
study quality improvement. He was founding directors of two new units; the first supporting primary care commissioning, receiving regional and national
recognition; later with the RCGP quality unit, developing and then delivering a number of national projects for a diverse client group and receiving
In 2002, he was awarded a Membership by distinction of the Faculty of Public Health. From 2003-2005 he was President of the Quality in Healthcare Forum of the Royal Society of Medicine. In January 2003, Dr. Wilson joined the Department of Health Strategy Unit, as a senior policy advisor to No.10, the Secretary of State and other ministers of health on medium and long term policy. His remit included work on chronic diseases, commissioning, organizational development and primary care. In 2010 Dr. Wilson was awarded an honorary Fellowship of the Royal College of Physicians for his work in health policy.
In February 2005 he joined the health consulting arm of PricewaterhouseCoopers where he leads their health care strategy and large scale performance improvement in hospitals and primary care trusts. He became a partner at PwC in 2007. At PwC he leads work on health strategy, commissioning, getting patient experience into health care and organizational change.
Mr. Stuart Anderson is the Managing Director & Regional Head Middle East for Standard & Poor's; based in their regional office at the Dubai International Financial Centre. He was appointed to this position in September 2011 and since then has significantly strengthened S&P's analytical presence in the region along with an expanded program of thematic research and thought leadership within the financial community. He is also the current Chairman of The Gulf Bond and Sukuk Association. Previously, Mr. Anderson had more than 20 years of experience with Standard Chartered Bank in business development, risk management and governance functions throughout East Asia and the Middle East.
Mr. Anderson's extensive knowledge of capital markets enable him to lead Standard & Poor's as an important participant within the Middle East's financial markets, as Standard & Poor's continues to engage with debt issuers, investors, intermediaries, policymakers and regulators across the region. Initially educated in New Zealand, he holds a Bachelor of Business degree from Curtin University in Australia and then qualified as a Chartered Accountant with Ernst & Young.
Mr. Edward Johnson is a project finance partner in the Squire
Sanders London office, with a particular focus on public-private
partnerships (PPP) and infrastructure development projects in the
transport and healthcare sectors.
Mr. Johnson has acted for public and private sector clients on a range of large scale domestic and international PPP projects with a particular focus on advising governments and public authorities on public-private partnerships. He has more than 15 years’ experience of public-private partnerships and has been involved in the development of innovative solutions which have gone on to become accepted as best practice in the market.
Mr. Johnson advises on all aspects of PPP projects and has regularly advised government clients on the public policy issues relevant to PPP projects. He also has a great deal of experience advising on the structure and scope of PPP projects to ensure that value for money and innovation is maximised for the benefit of government clients.
Mr. Johnson is recognised by The Legal 500 UK for PFI/PPP projects and is often quoted in PPP industry publications. He also spoke at the Washington DC conference of the International Municipal Lawyers Association in 2011 on the development of social infrastructure P3 Projects in the US.
- A1 Darrington to Dishforth project, UK. Representing the UK Government on the £245 million design, build, finance and operate project. This was the world's first highway project to adopt a payment mechanism based on management of congestion levels and average traffic speeds.
- A249 Stockbury to Sheerness project, UK. Representing the UK Government on the £335 million design, build, finance and operate project. This was the first UK highway project to include a road and rail bridge.
- M25 London Orbital motorway project, UK. Advising the UK Government on the procurement and planning stages of the £6 billion design, build, finance and operate project. This included a complete review of existing practices to adopt to the scale of this project.
- A13 London Thames Gateway project, UK. Representing the UK Government and Transport for London on the £400 million design, build, finance and operate project.
- A130 Essex County Council design,build, finance and operate project. Representing Essex County Council on the £160 million project, the first in the UK to be awarded by a local authority.
- Polish Trunk Road Network. Representing the Polish Department of Transport on the maintenance and operation of the Polish trunk road network through a public-private partnership.
- Representing the Governments of Tanzania, Kenya and Romania on flexibility and risk analysis studies for highway DBFO projects.
- Representing the Roads Service of Northern Ireland on the implementation of its pathfinding highways PPP programme.
- Greater Peterborough Hospital Project, UK. Representing a project sponsor on the £355 million hospital PPP project.
- Royal School of Military Engineering, Ministry of Defence PPP Project. Representing a project sponsor on £3 billion defence estate and training facilities project.
Mr. Khalid A. Al-Thebity is the managing partner and name partner of the affiliated office in Riyadh. He practices in the area of corporate, commercial, financial law matters and real estate, as well as on Saudi litigation and arbitration cases. Mr. Al-Thebity has been representing the Government of Saudi Arabia on several international law matters since 1996. He has advised major Insurance companies with respect to Saudi regulatory matters. He led the team that assisted four major Insurance companies to be incorporated in Saudi and to be listed on the stock exchange, Tadawul.
Mr. Al-Thebity has a broad transactional practice which is devoted primarily to the energy and real estate industry, with an emphasis on project development and finance matters. His general commercial practice includes the representation of a broad range of clients, including primarily energy and real estate, in general corporate and company matters. Mr. Al-Thebity has been the lead real estate counsel in some of the Saudi transactions. He has broad experience in all aspects of real estate and construction practice. In addition to the work he has done for the Saudi Arabian Capital Market Authorities, Mr. Al-Thebity advised clients on establishment of real estate funds.
- Assisted the Saudi Arabian Ministry of Health in determining the intellectual property rights (IPR) related to human betacoronavirus 2c EMC and in outlining the steps necessary to pursue addressing IPR and KSA’s interest in the Virus.
- Assisted the Saudi Arabian Ministry of Health in connection with matters relating to US Food and Drug Administration and Center for Disease Control and Prevention, in particular, on the documented cases of vCJD, attributed by the TSE Advisory Committee to Saudi Arabia, arising out of infected persons who had spent time in Saudi Arabia from 1980 to 1996.
- Assisted US companies and institutions specialized in health care negotiate joint ventures and establish presence in the Kingdom of Saudi Arabia.
- The lead Saudi lawyer in advising the Government of Saudi Arabia in connection with the “Gas Initiative” to open its natural gas industry to private investors.
- The lead Saudi lawyer in advising Eastern Petrochemical Company (SHARQ), a SABIC affiliate, on a $3.7 billion expansion project.
- Represented Dabbagh Group in SR451 million acquisition of the entire shares in Saudi Arabian Lubricating 011 Company (Petrolube) (which was owned by Saudi Arabian Oil Company (Saudi Aramco) and Mobil Investments SA).
- Advised various clients on the undertaking of real estate investments in Saudi Arabia.
- Represented several foreign companies in connection with establishing joint ventures in Saudi and purchasing interests in joint ventures.
- Led the team that advised Kingdom Holding and other consortium members in connection with the second GSM license in Saudi.
- Assisted the Government of Saudi Arabia in connection with compliance with WTO requirements and obligations.
- Assisted several Saudi agencies in drafting laws and regulations. In addition, Mr. Al-Thebity’s views and comments have been sought by many agencies on draft laws and regulations.
Mr. David W. Rowan has served as Chief Legal Officer and Secretary of Cleveland Clinic since June 2005. In 2006 he was appointed to a newly-created position of Chief Governance Officer and serves on Cleveland Clinic’s Board of Governors.
Mr. Rowan received his JD magna cum laude from Georgetown University Law Center in 1978 and a B.A. summa cum laude from the University of Toledo in 1975. He joined the law firm of Squire, Sanders & Dempsey, LLP upon graduation from law school and became a partner in 1987. He left Squire, Sanders to become the Chief Legal Officer of Cleveland Clinic in 2005. The law department that Mr. Rowan leads is responsible for all legal matters of Cleveland Clinic and its health system.
Mr. Rowan is a frequent speaker on health law and governance topics and has served on many not-for-profit boards. He currently serves as a Trustee of the Diversity Center, which is committed to social justice.
Mr. Malek Moosa is a hospital administration graduate and holds a Masters degree form the Royal College of surgeons in Ireland (RCSI). He is also a member of the American College of Healthcare Executives and involved with many local charity institutions. Additionally, Mr Moosa is actively involved in developing a patient centric healthcare system in the region to enhance patient experiences and outcomes.
Dr. Curtis Mark Rimmerman, MD, MBA, is the initial holder of the Gus P. Karos Endowed Chair in Clinical Cardiovascular Medicine. He is a staff cardiologist in the Section of Clinical Cardiology, the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, at the Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He is also Director of the Cleveland Clinic Cardiovascular Medicine Affiliate Programs. Prior to this he was Medical Director for the Cleveland Clinic Westlake, Lakewood, and Avon Pointe Family Health Centers. Dr. Rimmerman is certified by the American Board of Internal Medicine in Internal Medicine and the subspecialty of Cardiovascular Diseases. He is also certified by the National Board of Echocardiography and the American College of Physician Executives.
Dr. Rimmerman is a native of Cleveland, Ohio, completing his undergraduate studies at Case Western Reserve University, graduating Magna Cum Laude with a degree in chemistry (Phi Beta Kappa). He received his Doctor of Medicine degree from the Case Western Reserve University School of Medicine. Dr. Rimmerman completed his internship and residency in Internal Medicine at Vanderbilt University Medical Center in Nashville, Tenn., followed by a cardiology fellowship at the Krannert Institute of Cardiology at Indiana University Medical Center in Indianapolis, Indiana. Dr. Rimmerman continued his education while on Staff at Cleveland Clinic at the Case Western Reserve University Weatherhead School of Management, earning a Master's Degree in Business Administration.
Dr. Rimmerman was appointed to the professional Staff of Cleveland Clinic in 1993.
Professor Kristi L. Koenig, MD, FACEP, FIFEM is an internationally
recognized expert in the fields of Homeland Security, Disaster and
Emergency Medicine, Emergency Management, and Emergency Medical
Services. A systems thinker, with strong academic and health policy
background, she is widely published and internationally sought for
lecture-presentations. She has been an invited consultant to the Joint
Commission, Federal Emergency Management Agency (FEMA), State of
California, and Government of Taiwan among others. A board-certified
Emergency Physician, she serves as the Director of Public Health
Preparedness for the University of California at Irvine since October
In April 1999, the Secretary of the Department of Veterans Affairs (VA) appointed Dr. Koenig for a 5-year term as National Director of the Emergency Management Strategic Healthcare Group and Principal EM Advisor to the Under Secretary for Health where she led Emergency Management for the Nation's largest integrated healthcare system. She concurrently held a position as Clinical Professor of Emergency Medicine at the George Washington University School of Medicine and Health Sciences. Prior to joining VA, Dr. Koenig was Director of Prehospital and Disaster Medicine at Highland Hospital in Oakland, California, and Associate Professor of Emergency Medicine at the University of California, San Francisco.
In 1996, Dr. Koenig was invited to be Co-Director of the Accident and Emergency Department at St. George's Hospital National Health Service Trust in London, where she concurrently was Director of Undergraduate Medical Student Education and Honorary Senior Lecturer at the University of London.
Throughout her career Dr. Koenig has held multiple appointments, including the World Association for Disaster and Emergency Medicine Board of Directors, the Joint Commission's Committee on Healthcare Safety, Chair of the Society for Academic Emergency Medicine's Disaster Medicine Task Force, the American College of Emergency Physicians (ACEP) liaison to FEMA, the ACEP Ebola Expert Task Force, and the State of California EMS Commission. She is Senior Health Policy Advisor for the Institute for Global and Regional Readiness in Washington, DC, Consultant to the American Medical Association on Core Disaster Life Support and ACEP Ambassador to Taiwan and Germany.
Dr. Koenig has published three books including a definitive reference: Koenig and Schultz's Disaster Medicine: Comprehensive Principles and Practices. She has authored more than 100 peer-reviewed articles, including publications in the New England Journal of Medicine and the Journal of the American Medical Association. She has been Co-Editor of the Disaster Medical and Public Health Preparedness Journal Special Ebola Issue, Associate Editor for Academic Emergency Medicine, Journal Watch Emergency Medicine senior editor, and an NIH grant reviewer. Her research grants include a National Science Foundation award to study hospital evacuation after California's 1994 Northridge Earthquake.
With expertise in surge capacity, crisis care, disaster triage, and medical response to weapons of mass destruction, Dr. Koenig has delivered nearly 500 invited lectures in about 35 countries. She was an invited visiting professor in India, providing training on disaster and terrorism management just a few months prior to the 2006 Mumbai train bombings. Dr. Koenig is Affiliate Faculty at the University of California at Los Angeles' Center for Public Health and Disasters, the Urban Water Research Center, and internationally for the European Master of Disaster Medicine (Visiting Professor of the Universita degli Studi del Piemonte Orientale, Vercelli, Italy and of the Vrije Universiteit Brussel, Brussels, Belgium) and Adjunct Professor, School of Public Health, Faculty of Health, Queensland University of Technology, Brisbane, Australia. She is a National American College of Emergency Physicians Media Spokesperson, is regularly featured in the news, and has provided Federal Congressional Testimony on Public Health Preparedness. In 2012, she was awarded a Fulbright Scholarship, University of Eastern Piedmont, Italy. The International Federation for Emergency Medicine (IFEM) awarded her the prestigious “Order of IFEM” Fellowship.
An honors graduate in applied mathematics from the University of California at San Diego, Dr. Koenig received her medical degree from Mount Sinai School of Medicine in New York and completed an Emergency Medicine Residency at Highland Hospital in Oakland, California, serving as Chief Resident in her final year. A fellow of the American College of Emergency Physicians, Dr. Koenig is currently Professor of Emergency Medicine and Founding Director of the International EMS & Disaster Medical Sciences Fellowship at the University of California at Irvine, School of Medicine .
Mr. Abboud Bejjani is Regional Vice President for AbbVie
Biopharmaceutical for the MEAP Region, following the separation of
Abbott into two publicly traded companies: Abbott & AbbVie. Mr. Abboud
joined Abbott in 1998 as Financial Planning Manager for the Middle East
He began his career in 1992 at Arthur Andersen & Co. In 1998 he joined Abbott's Middle East Regional Office and progressed through positions of increasing responsibility in Finance until becoming Regional Finance Director Middle East & North Africa in 2001. Mr. Bejjani later took the position of Country Manager for the Levant Region before becoming General Manager Gulf & Levant Region in 2005. In 2012 he took over the position of Regional Director Propriety Product Division for the Middle East, Africa & Pakistan Region (MEAP).
Mr. Abboud carries a Master Degree in Finance from St Joseph University and is a member of the international Management Accountants at the New Jersey Board. Throughout his career he worked in several countries such as United States, Canada, Lebanon, Greece, Kuwait, Saudi Arabia and UAE.
Dr. John Duke Anthony is the Founding President and Chief Executive Officer of the National Council on U.S.-Arab Relations, and currently serves on the United States Department of State Advisory Committee on International Economic Policy and its Subcommittee on Sanctions. In 2012, he chaired and was the core lecturer in the Council's 26th Annual 10-Week University Student Summer Internship Program's Academic Seminar on Arabia and the Gulf. For the past 38 years, he has been a consultant and regular lecturer on the Arabian Peninsula and the Gulf for the Departments of Defense and State. He is former Chair, Near East and North Africa Program, Foreign Service Institute, U.S. Department of State as well as former Chair of the Department's Advanced Arabian Peninsula Studies Seminar. A life member of the Council on Foreign Relations since 1986, Dr. Anthony has been a frequent participant in its study groups on issues relating to the Arabian Peninsula and Gulf regions and the broader Arab and Islamic world. More recently, Dr. Anthony was elected to the Board of Advisors of the Yemen College for Middle Eastern Studies. For the Fall 2012 semester, in addition to fulfilling his duties as Council President and CEO and Adviser to the Department of State, he was appointed Dean's Chair in International Studies and Political Science at the Virginia Military Institute in Lexington, Virginia, where he taught the Institute's first-ever course on "Politics of the Arabian Peninsula" to First (Senior) and Second (Junior) classmen.
On June 21, 2000, on the occasion of his first official visit to the United States, H.M King Muhammad VI of Morocco knighted Dr. Anthony, bestowing upon him the Medal of the Order of Ouissam Alaouite, the nation of Morocco's highest award for excellence. In addition to heading the National Council, consulting, lecturing, and serving as an Adjunct Faculty Member of the U.S. Department of Defense's Defense Institute for Security Assistance Management (DISAM) since 1974, Dr. Anthony has been an Adjunct Professor at the Georgetown University School of Foreign Service's Center for Contemporary Arab Studies since 2006. There, he developed a course for graduate students on "Politics of the Arabian Peninsula," the first such semester-long academic course to be offered at any American university. In 2007, he was Visiting Lecturer at the Oxford Center for Islamic Studies. In 2008 he was the Distinguished Visiting Professor at the American University in Cairo's HRH Prince Alwaleed Bin Talal Bin ‘Abdalaziz Al-Sa'ud Center for American Studies.
In 1983, Dr. Anthony received DISAM's Distinguished Achievement Award, one of three granted to American Middle East specialists in the Institute's history. In March 1989, the Kappa Alpha Order's National Executive bestowed upon him its Distinguished Public Service Award for Excellence "through a strenuous and useful Life of Service to others." In 1993, he received the U.S. Department of State's Distinguished Visiting Lecturer Award, one of three awarded over a span of 25 years in recognition of his preparation of American diplomatic and defense personnel assigned to the Arabian Peninsula and the Gulf states. In 1994, he received the Stevens Award for Outstanding Contributions to American-Arab Understanding. In May 2008, the Rotary Club of the Nation's Capital bestowed upon him its first-ever Local Giants Leadership Award.
Dr. Anthony is the only American to have been awarded a Fulbright Fellowship in the former People's Democratic Republic of Yemen (1969-1970). In 1971, he was cosponsored by the British Ministry of Foreign Affairs and the U.S. Department of State as the sole American scholar to observe at firsthand the process by which the British ceased administering the defense and foreign relations for nine Arab states lining the coastal regions of eastern Arabia and the Gulf. His long experience in Yemen led to Dr. Anthony being asked to serve as an international observer in all four of Yemen's presidential and parliamentary elections.
Dr. Anthony is the only American to have been invited to each of the Gulf Cooperation Council's Ministerial and Heads of State Summits since the GCC's inception in 1981. (The GCC is comprised of Bahrain, Kuwait, Qatar, Oman, Saudi Arabia, and the United Arab Emirates). Since 1986 and continuing until the present, Dr. Anthony has accompanied more than 200 Members of Congress, their chiefs of staff, defense and foreign affairs advisers, and legislative and communications directors on fact-finding missions to the Arab world. From 1996 until the present, he has also served as the principal scholar-escort for delegations to various GCC countries, Egypt, and Yemen comprised of 132 officers assigned to the staff of the Commander, U.S. Central Command, including Generals J.H. Binford Peay III, Anthony C. Zinni, Tommy Franks, John P. Abizaid, David Petraeus, James Mattis, and Admiral William Fallon.
Dr. Anthony is the author of three books, the editor of a fourth, and has published more than 175 articles and essays, and five monographs dealing with America's interests and involvement in the Arab countries, the Middle East, and the Islamic world. His best-known works are Arab States of the Lower Gulf: People, Politics, Petroleum; The Middle East: Oil, Politics, and Development (editor and co-author) and, together with J. E. Peterson, Historical and Cultural Dictionary of the Sultanate of Oman and the Emirates of Eastern Arabia. Among his more recent publications are The United Arab Emirates: Dynamics of State Formation, Abu Dhabi, UAE: Emirates Center for Strategic Studies and Research (ECSSR), 2002; "The Future Significance of the Gulf Cooperation Council," in Global Strategic Developments: A Futuristic Vision, Abu Dhabi, UAE: ECSSR, 2012; "The Intervention in Bahrain through the Lenses of its Supporters" and "Challenges Facing NATO in Afghanistan, Libya, and Iraq," all four published by ECSSR in the Summer and Fall of 2011; "War with Iran: Regional Reactions and Requirements," published by Middle East Policy and the National Council on U.S.-Arab Relations, 2008; "Strategic Dynamics of Iran-GCC Relations," in Jean-François Seznec and Mimi Kirk, eds., Industrialization in the Gulf: A Socioeconomic Revolution, New York: Routledge, 2011; and "Measuring the Iraq War 'Accomplishments' Through the Lens of Its Authors: A Preliminary Assessment": a revised and edited version of an address presented to the Axis for Peace conference held in Brussels by Voltaire Network, 2005, published by the National Council.
In addition to being the founder and chief facilitator and moderator of the Annual Arab-U.S. Policymakers Conference, now in its 21st year, Dr. Anthony has been a founder, board member, and Secretary of the U.S.-GCC Corporate Cooperation Committee; founding President of the Middle East Educational Trust; co-founder of the Commission on Israeli-Palestinian Peace; founding President of the Society for Gulf Arab Studies; co-founder and board member of the National Commission to Commemorate the 14th Centennial of Islam; and founder and former chairman of the U.S.-Morocco Affairs Council. In 2006 he was elected Vice-President and member of the Board of Directors of the International Foreign Policy Association in Washington, D.C.
After completion of his U.S. Army active duty military service, the Commonwealth of Virginia granted Dr. Anthony a four-year State Cadetship Award which allowed him to enroll at Virginia Military Institute (VMI), where he received his Bachelor's Degree in History. At VMI, he was elected president of his class all four years in addition to serving as president of the Corps of Cadets' Government General and Executive Committees during his First Class Year. He later earned a Master of Science Degree in Foreign Service (With Distinction) from the Edmund A. Walsh Graduate School of Foreign Service at Georgetown University, where, in addition to holding one of three University Scholar Awards, he was inducted into the National Political Science Honor Society. He holds a Ph.D. in International Relations and Middle East Studies from the Johns Hopkins University School of Advanced International Studies (SAIS) in Washington, D.C., where he held a National Defense in Foreign Language Scholarship for Arabic, was awarded a Fulbright Fellowship, and was appointed in 1973 to SAIS' full-time faculty while still a student. For nearly a decade, Dr. Anthony taught courses on the Arabian Peninsula and the Gulf States at SAIS. He has been a Visiting and Adjunct Professor at the Defense Intelligence College, the Woodrow Wilson School of Government and Foreign Affairs at the University of Virginia, the Universities of Pennsylvania and Texas, the U.S. Naval Postgraduate School, and a regular lecturer at the National War College.
Dr. Anthony passed his proficiency exam in French at the Georgetown University's School of Foreign Service in 1966. He passed his proficiency exam in Arabic at the Johns Hopkins University School of Advanced International Studies in 1969 following study there as well as at Princeton University and the American University in Cairo's Center for Arabic Study Abroad.
Dr. Anthony is married to Cynthia Burns McDonald, Director of the Washington, D.C. Office of the American University in Cairo, and has twin sons.
Susan Sheehan is President and Chief Operating Officer of Huntsman Cancer Foundation. Her 30-year career in non-profit leadership has been dedicated to eliminating suffering and advancing the well-being of family, community, and the global human family. Ms. Sheehan has worked at Huntsman for the past 11 years.
Ms. Paige Peterson, works with the Huntsman Cancer Institute and Foundation, focusing primarily on cancer research and patient needs: a cause close to her heart. Born in Marin County, California, Ms. Peterson is a renowned American painter and bestselling author and illustrator. Ms. Peterson has worked at Huntsman for the past seven years.
Dr. Randall Burt is also director of the Familial Colon Cancer Clinic and co-director of the Family Cancer Assessment Clinic at Huntsman Cancer Institute. He is a member of the Cancer Control and Population Sciences Program. In addition, he is a professor in the Department of Medicine, Division of Gastroenterology, at the University of Utah School of Medicine. He holds the D. Keith Barnes, MD, and Ida May "Dotty" Barnes, RN, Presidential Endowed Chair in Medicine.
Dr. Burt is a gastroenterologist with primary interest in familial risk and inherited syndromes of colorectal cancer. He and members of his group have demonstrated that inheritance is a critical determinant in colon cancer, possibly playing a role in up to a third of all cases. In 1987, a group led by Ray White, PhD and Dr. Burt, discovered the chromosomal location of the gene for a dangerous inherited colon cancer syndrome called familial adenomatous polyposis (FAP). Soon after, the sequence of the gene and mutations responsible for the syndrome were identified by this group. It soom became apparent that this gene was an early mutation in the large majority of colon cancers and premalignant adenomatous polyps. An important outcome of this research is that genetic testing soon became available to identify persons with the inherited syndrome.
Dr. Burt looks for new gene mutations that cause predisposition to common colon cancers, by utelizing the Utah Population Data Base, a data base that combines the Utah Cancer Registry (a SEER registry) and the Utah genealogies. Large families (up to 20,000 persons) are available in this resource for gene discovery. As part of a large, randomized, controlled study, he researched the impact of diet on the occurrence of colon cancer, and now directs a chemoprevention study involving subjects with familial adenomatous polyposis. Dr. Burt also conducts research in each of the inherited colon cancer syndromes, including familial adenomatous polyposis, Lynch syndrome (hereditary nonpolyposis colorectal cancer), Peutz-Jegher disease, familial juvenile polyposis syndrome, Cowden syndrome, serrated polyposis syndrome (hyperplastic polyposis syndrome) and others. These studies involve clarifying the phenotype and the molecular-genetic aspects of these diseases.
Clinical care for persons with these syndromes, including genetic testing and endoscopy, is a major part of Dr. Burt's academic practice. The determination of famial risk including appropriate risk stratification and screening, is also a part of both research and clinical care. Extensive use of the Utah Population Data Base is used in these investigations to precisely determine colon cancer risk in families without one of the known interited syndromes.
Dr. Burt received his medical degree from the University of Utah in 1974. He completed an internship and residency in internal medicine at Washington University and Barnes Hospital in St. Louis, Missouri, and completed a fellowship in gastroenterology at the University of Utah School of Medicine in 1979.
Dr. Peter J. Hotez, M.D., Ph.D. is Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine where he is also chief of a new Section of Pediatric Tropical Medicine and the Texas Children's Hospital Endowed Chair of Tropical Pediatrics. He is the President of the Sabin Vaccine Institute.
Dr. Hotez is an internationally-recognized physician-scientist in neglected tropical diseases and vaccine development. He leads the only product development partnership for developing new vaccines for hookworm infection, schistosomiasis, and Chagas disease, diseases affecting hundreds of millions of children and adults worldwide. In 2006 at the Clinton Global Initiative he co-founded the Global Network for Neglected Tropical Diseases to provide access to essential medicines for hundreds of millions of people
He obtained his undergraduate degree in molecular biophysics from Yale University in 1980 (phi beta kappa), followed by a Ph.D. degree in biochemical parasitology from Rockefeller University in 1986 and an M.D. from Weil Cornell Medical College in 1987. Dr. Hotez has authored more than 300 original papers and is the author of the acclaimed Forgotten People, Forgotten Diseases (ASM Press).
Dr. Hotez served previously as President of the American Society of Tropical Medicine and Hygiene and founding Editor-in-Chief of PLoS Neglected Tropical Diseases. He is an elected member of the Institute of Medicine (IOM) of the National Academy of Sciences and in 2011 he was awarded the Abraham Horwitz Award for Excellence in Leadership in Inter-American Health by the Pan American Health Organization of the WHO.
In 2015 the White House and U.S. State Department selected Dr. Hotez as a United States Science Envoy.
Dr. Kashef Ijaz is member of the CDC's senior leadership and oversees the science and research agenda for his division and ensures that the scientific projects, protocols and epidemiologic investigations are conducted based on established scientific/epidemiologic methods. He also provides consultation and guidance on programmatic aspects to the branches in his division.
In the recent past he has been the Senior Regional Advisor for Field Epidemiology and Laboratory Training Program for the Middle East and North Africa Region in the Division of Public Health Systems and Workforce Development. During his tenure at CDC, he has also served as the Chief of the Outbreak Investigations team in the Division of Tuberculosis Elimination, and then as Chief of the Field Services and Evaluation Branch in the Division of Tuberculosis Elimination. As the lead for the outbreak investigations team, he trained numerous Epidemic Intelligence Service Officers and also responded to numerous TB outbreak investigations both in the United States and internationally. In his appointment as the Chief of the Field Services and Evaluation Branch, he led one of the largest branches (with a budget of over $100 million) at CDC with staff of over 70 people including public health advisors, epidemiologists and medical officers. He was responsible for the TB control activities in the entire United States and its territories (including funding support and technical assistance). He helped update a data-driven formula for funding of TB control programs in the country as well as developed capacity to conduct program evaluation, including a program evaluation network to build evaluation capacity at state and local levels.
Prior to coming to CDC, Dr. Ijaz was the Research Assistant Professor, Department of Internal Medicine, University of Arkansas for Medical Sciences in Little Rock. He is a physician trained in internal medicine and has a Masters degree in Public Health from University of Oklahoma Health Sciences Center. He is also the adjunct Associate Professor in the Department of Epidemiology, Rollins School of Public Health, Emory University. His research involves prevention and control of infectious diseases, molecular epidemiology and genotyping of Mycobacterium tuberculosis. Dr. Ijaz has more than 40 publications in peer-reviewed journals and a book chapter.
Dr.Faisal Almazroua is a board certified Emergency Medicine consultant at King Saud Medical City (KSMC) in Riyadh. After graduating from college of medicine, King Saud University in 2002 he joined King Abdulaziz Medical City to do his residency training in Emergency Medicine. After the certification, he joined King Saud Medical City as an acting consultant in the department of Emergency Medicine. He was also the deputy program director for the residency training program. In 2011 he was accepted to do Clinical Research fellowship at University of California-San Diego (UCSD) where he had the chance to do a master degree of clinical research in the same time at UCSD. In 2013, he pursued his fellowship at University of California-Irvine (UCI) where he did an International EMS/disaster medical sciences fellowship at the center of disaster medical science (CDMS). Early this year he joined KSMC back as a consultant in the department and a member of the committee to establish a research center at KSMC.
Dr. Ali Mokdad, PhD, is Director of Middle Eastern Initiatives and Professor of Global Health at the Institute for Health Metrics and Evaluation (IHME) at the University of Washington. In this role, he is building IHME's presence in the region through new research projects, dissemination and uptake of IHME's methods and results, and consultation with regional leaders in population health.
Prior to joining IHME, Dr. Mokdad worked at the CDC, starting his career there in 1990. He served in numerous positions with the International Health Program; the Division of Nutrition and Physical Activity; the National Immunization Program; and the National Center for Chronic Diseases Prevention and Promotion, where he was Chief of the Behavioral Surveillance Branch.
Dr. Mokdad also managed and directed the Behavioral Risk Factor Surveillance System (BRFSS), the world’s largest standardized telephone survey, which enables the CDC, state health departments, and other health and education agencies to monitor risk behaviors related to the leading causes of morbidity and mortality in the United States.
Dr. Mokdad has published more than 250 articles and numerous reports. He has received several awards, including the Global Health Achievement Award for his work in Banda Aceh after the tsunami, the Department of Health and Human Services Honor Award for his work on flu monitoring, and the Shepard Award for outstanding scientific contribution to public health for his work on BRFSS.
He received his BS in Biostatistics from the American University of Beirut and his PhD in quantitative epidemiology from Emory University.
Dr. Abdullah Sulaiman Al Amro, MD, FRCPC, was CEO of Saudi Arabia's King Fahad Medical City (KFMC) until from 2004 -2013. Known by many as the largest and most advanced medical complex in the Middle East, Dr. Al Amro has proven himself locally and throughout the Islamic medical community to be a strong leader.
He graduated from King Faisal University in Dammam and, after training in radiation oncology in the Kingdom of Saudi Arabia (KSA), obtained postgraduate training in Ottawa, Canada, and then returned to Saudi Arabia.
Dr. Al Amro has repeatedly proven his special aptitude for organizational and administrative work. He was a member of the teams that established health outreach programs throughout the Kingdom of Saudi Arabia, including:the National e-Health Center; the Prince Faisal Bin Bandar Oncology Center;the King Abdulaziz Oncology Center-Jeddah; King Faisal Specialist Hospital (KFSH)and Research Center business program; the KFSH and Research Center reference laboratory; and the Saudi Cancer Support Society (SCSS)
During his tenure as CEO, the growth of the institution, as reflected in the annual budget, grew from $80 million in 2004 to more than a half billion by 2013. As a true manager and visionary developer, he staffed King Fahad Medical City with highly qualified multinational professionals.
Dr. Scott McNabb, PH.D., M.S., worked for 13 years at the Oklahoma State Health Department, prior to joining the Epidemic Intelligence Service (EIS) and serving the 2-year EIS residency in New Orleans, LA. Since 1993, most of his professional efforts have focused on supporting those in underdeveloped, underserved global settings. Before retirement from the CDC in 2010, he served as Associate Director for Science; Public Health Informatics and Technology Program Office; Office for Surveillance, Epidemiology, and Laboratory Services.
From 2006 – 2008, Dr. McNabb directed the Division of Integrated Surveillance Systems and Services, National Center for Public Health Informatics, CDC. He is Research Professor and Director of the King Abdullah Fellowship Program at Emory University, Rollins School of Public Health. Teaching two classes, GH 504 Effective Oral Presentations for Public Health Professionals and GH 592 Successful Scientific Writing for Public Health Professionals, he also teaches in short-course format, including in the University of Michigan Graduate Summer Session. Having mentored 29 students through their M.P.H. or Ph.D., plus 14 fellows through the CDC Public Health Prevention Specialists program, he is jointly appointed in the Hubert Department of Global Health and Department of Epidemiology. He holds an appointment as Adjunct Professor, Department of Epidemiology and Biostatistics, College of Public Health and Health Informatics, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia.
Promoted to Distinguished Consultant in 2005 and nominated for the 2005 CDC Charles C. Shepard Award, Dr. McNabb completed the 2004 Senior Executive Services (SES) candidate development program and is certified by the Office of Personnel Management. Dr. McNabb serves on the Editorial Board, Epidemiology and Global Health and in private practice as a Senior Consultant and Managing Partner, Public Health Practice, LLC and Senior Consultant, Global Strategies, LLC
Dr. Muhammad Chaudry a career food technologist received his academic education in Pakistan, Lebanon and the United States with a Ph.D. from the University of Illinois at Champaign-Urbana.
For 15 years he worked in the food industry at various technical and management positions, responsible for total quality, quality assurance, human resources and employee training. For the past 30 years, Dr. Chaudry has been managing halal certification programs for the Islamic Food and Nutrition Council of America (IFANCA). Under his administration, halal certification by IFANCA has expanded to over 4000 production sites in 56 countries. Halal certified products include meat and poultry, seafood, food products, food ingredients and chemicals, nutritional products and supplements, cosmetics, personal care products, household products, vaccines, food processing chemicals, sanitation chemicals and packaging materials.
He is a member of the Institute of Food Technologists and expert consultant to the World Organization for Animal Health. He has written several articles and papers in technical journals as well as co-authored a book about Halal Food Production published by CRC PRESS. He was an international delegate for food safety workshops conducted in India, under the sponsorship of the United Nations International Trade Center and the American Spice Trade Association.
Dr. Chaudry is experienced in the management of not-for-profit organizations and industrial corporations in a cross-functional environment.
Before, joining University of Chicago Medicine, Mr. Emilio M. Williams-Lopez served as Strategic Advisor for hospitals in the US and abroad in the areas of coordinated care, patient experience, and new market development, before joining UCM.
Mr. Williams-Lopez worked with Medpoint Health Partners and their clients around the globe, consulting in different aspects multinational and multicultural hospital management. Clients included University of California San Diego, Northwestern Memorial Hospital and Dupont Hospital for Children.
From 2001 to 2011, Mr. Williams-Lopez led several high-profile, innovative projects within Johns Hopkins Medicine in Baltimore. He was in charge of developing strategies, and their implementation, to diversify the customer base of Hopkins at home and abroad. Mr. Williams-Lopez conceived and launched Hopkins’ first Cultural Competency curriculum, as well as the first formal Customer Relationship Management (CRM), a program aimed at securing the loyalty of Hopkins’ patients and referring physicians through a unique combination of operational coordinated care and traditional marketing. This CRM program allowed Hopkins to double its number of out-of-town patients in only three years. He was also part of the Center for Innovation in Quality Patient Care, an internal think-tank that develops patient-centered and safety programs.
Other initiatives in his portfolio included medical interpretation improvement, as well as physician-focused educational programs, such as JHM Interactive. Before joining Hopkins in July of 2001, Mr. Williams-Lopez had accumulated extensive experience as an international consultant and journalist.
Mr. Bader ALHablani gained his Health Records Technician diploma from the Training and Development Department at King Faisal Specialist Hospital and Research Centre (KFSH&RC) in Riyadh, Saudi Arabia in 2004. In 2011 he received a Bachelor's of Science in Health Information Management from the University of Kansas and in 2012 he received a Master's of Science in Health and Rehabilitation Sciences with a Concentration in Healthcare Supervision and Management from the University of Pittsburgh, USA.
In 1998, Mr. ALHablani began his career at KFSH&RC, where he progressed through positions of increasing responsibilities in the management of medical records until he became the acting supervisor of the File Area in the Medical Records Department in 2002. Mr. ALHablani later took the position of health records technician (coder) at the same department in 2004. In 2013 he took over a position as the Section Head of Registries Core Facility, Department of Biostatistics, Epidemiology and Scientific Computing Department, KFSH&RC.
Mr. ALHablani has been a member of the American Health Information Management Association (AHIMA) since 2005. He has two credentials from AHIMA: Certified Healthcare Privacy and Security (CHPS) and Registered Health Information Administrator (RHIA). He was a member of a sub-committee for the Health Information Exchange project as well as a supervisor for the establishment of the national neural tube defects registry.
Mr. ALHablani's research interests include Disease Registries, Clinical Terminologies (i.e. SNOMED-CT), Clinical Classifications (i.e. ICD-10), Electronic Health Records (EHRs), and Healthcare Privacy and Security.
Dr. Bothyna Murshid is a highly qualified consultant who is current employed by the National Commission for Academic Accreditation and Assessment (NCAAA).
Dr. Murshid has a doctoral degree in Nursing Science (Clinical Research: Human Responses to Chronic Illness) from the Yale School of Nursing, Yale University, USA. Additionally, Dr. Murshid has received a Masters Degree in Nursing Science in Health Services Administrative and Patient Care Management, from the University of Michigan, USA; and, she received a Bachelors of Nursing Science from the College of Nursing, King Saud University, Saudi Arabia. Dr. Murshid has worked at different nursing departments at both the University of Michigan and Yale.
Dr. Murshid was the former Dean of the College of Nursing, King Saud bin Abdul-Aziz University for Health Sciences (KSAUHS), and currently is an Assistant Professor. She is a member of national and international committees and association such as American Diabetes Association; American Public Health Association; and the Women for Peace. She was also the Chair person to establish and commission 3 nursing colleges in Riyadh, Jeddah and Al Ahsa.
Dr. Murshid is a key speaker and presenter in many national and international nursing and health related scientific meetings and conferences in addition to presenting and participating in conferences related to academic accreditation, quality assurance and assessment.
Dr. Rafat Qahoush, PhD, R.N., is the President and CEO of California School of Health Sciences (CSHS) and California Career Institute in Los Angeles, California (USA), providing medical and allied health clinical training, professional development, test preparation classes, English as a Second Language (ESL) programs, and certification courses at national and international levels. Dr. Qahoush also serves as a member of the adjunct faculty at California State University, Long Beach and California State University, Dominguez Hills where he teaches courses on healthcare policy and economics, research methods, testing and evaluation, ethics, human diversity, and health promotion and disease prevention.
As an educator, businessman and registered nurse, Dr. Qahoush understands the struggle between innovation and cost. Since 1998, his passion for healthcare and education has led to his international work in the field of healthcare consultation and training. His initial focus was on transferring affordable innovative technology and knowledge to Middle-East countries, working with the Jordan Royal Medical Services in Amman, Jordan. Today, he continues to bring attention to the role of innovation in health care and the challenge of providing cutting-edge treatment that is also cost effective. His vast experience includes working with U.S., Iraqi, Omani, Jordanian, and Saudi healthcare systems.
Prior to his current roles, Dr. Qahoush held a clinical research associate position at Kaiser Permanente. He received his B.S. Degree in Nursing from the University of Jordan; his M.S. Degree in Nursing from the University of California, Los Angeles; and, his PhD in Nursing from the University of California, San Francisco.
Dr. Mahesh Krishnan, MD, MPH,MBA, FASN, is currently the International Chief Medical Officer and Head of Research and Development and Public Policy at DaVita.
Dr. Krishnan is well experienced in healthcare. He manages medical quality in each of DaVita’s international regions for kidney care. Additionally, Dr. Krishnan is responsible for medical policy for all DaVita businesses in DC and sits as the Chief Data Officer at DaVita. He is responsible for strategic partnerships for technology and Research and Development.
Before DaVita, Dr. Krishnan was in charge of ESA’s at Amgen, for Epoetin Alpha and Darbepoetin in dialysis. Prior to that, Dr. Krishnan was in practice in Northern Virginia for nearly five years.
After receiving his bachelor's degree in premedicine from Pennsylvania State University, Dr. Krishnan earned his medical degree from the Jefferson Medical College at Thomas Jefferson University. He also holds a master's degree in Public Health from Johns Hopkins University. Additionally, he has completed an MBA in medical services management at the Johns Hopkins Carey School of Business in Baltimore, Maryland.
Dr. Krishnan is a member of the American College of Physicians, American Medical Association, American Society of Nephrology and National Kidney Foundation. He currently serves on the editorial board of Nephrology News and Issues and his writing has been published many times in renal care and research publications around the world.
Dr. Alazemi is CEO of Prince Mohammad Bin Abdulaziz Medical City (PMMC) Project located in Skaka City, which is in Al-Jouf region. This City is going to be one of five medical cities that will contribute to the Kingdom of Saudi Arabia Ministry of Health strategy to provide tertiary and quaternary care, by expanding its availability to patients in the northern regions of the Kingdom. The current population of these widely distributed regions is 2,148,000, and is continually increasing.
Construction of the City is scheduled for inauguration in 2016. Developing the strategies, vision, and mission of the City is underway, planning for a capacity of 1000 beds with provision of services related to cancer, cardiac services, neuroscience, ophthalmology, and rehabilitation services, in addition to a main hospital through which medical and surgical specialty and subspecialty services will be provided. As part of this planning, a program for building qualified health cadres was established, and a budget was allocated for national and international scholarships in all medical, technical, nursing, and support services .
The City is committed to professional standards of patient safety, while providing healthcare services through its mission to be the prime referral center in the Kingdom's northern regions. It will provide health services with superior professionalism and international quality based on leading technology and continuous implementation of state-of-the-art teaching, training, and research practices.
Managing the program of building and establishing PMMC is being handled applying the tools of project management by a team formed of full time and part time experts and consultants from a well known academic national & international specialized institutions. The project team office is temporarily located in Riyadh.
Dr. Alazemi is on the Saudi Board and Arab Board in family medicine. He has an Executive Master of Health Administration from Washington University, Saint Louis; a Diploma of Child Health (DCH), Royal College of Physicians & Surgeons in Ireland; a MBBs, College of Medicine, King Saud University, Riyadh Saudi Arabia.
Dr. Hamad Mohammad Al Omar MD, MBA, is the Founder and Chairman of National Blood and Cancer Center (NBCC), the first private and stand-alone blood and cancer center in Riyadh, Saudi Arabia.
Dr. Hamad is a subspecialty consultant in Hematology, Blood and Marrow Transplantation, was trained in Canada and USA, and holds a physician Executive Master of Business Administration from Tennessee, USA.
During his work at the King Faisal Specialist Hospital and Research Center (KFSH&RC) – the premier tertiary healthcare facility in the Middle East – he has achieved the followings:
- Established the department of Hematology, Oncology and Blood and Marrow Transplantation at KFSH&RC Jeddah. Served as a Hematologist with focus on Malignant Hematology and Stem Cell Transplantation. Graduated Basic Research activity in the field of Tumor Immunology and Dendritic Cell Culture and activation.
- He co-founded Jeddah BioCity, the first biotechnology company in Saudi Arabia. A joint venture between KFSH&RC-Jeddah and leading.
- Dr. Al-Omar has been active in entrepreneurship and VC/PE fields where he has achieved the following: Founder and Chairman of Specialized Academy for Medical Training (SAMT); that has graduated more than 4000 students with Diploma certificates in different medical specialties. He was also Founder and Chairman of DNA-Advanced Laboratory (DNA-AL);established the first commercial GMO testing laboratory in GCC.
- Dr Al-Omar was Founder and Chairman of Disease Management Company (DMC) and Mobile Health Company (MHC); both firms are the first to provide mobile health services in MENA region.They are working with more than 10 telecom operators in the region. More recently, its mobile health application and service under the name of “Qareboon” has won the best M-Government Award in healthcare in the Arab World during the “Government Summit 2015” in Dubai.
- He is also Founder and Chairman of National Blood and Cancer Center (NBCC); the first private and stand-alone blood and cancer center in Saudi Arabia.
- In the VC/PE activities, Dr. Al-Omar has made Exit and acquisition deals with a total value of more than SAR 300 Million. Internationally, he was a Venture Partner with Inventages; a Life Science VC firm based in Geneva with a total of US$1.5 billion under management.
- In the VC/PE activities, Dr. Al-Omar has made Exit and acquisition deals with a total value of more than SAR 300 Million. Internationally, he was a Venture Partner with Inventages; a Life Science VC firm based in Geneva with a total of US$1.5 billion under management.
As a Healthcare consultant, Dr. Al-Omar has performed the following:
- Participated as a facilitator for the strategy development team of the national strategic planning project for health professions education in Saudi Arabia, a study performed for the Ministry of Higher Education.
- He was a member of the core team working with McKensey & Co that developed a strategic review and restructuring plan for KFSH&RC Healthcare System. He was also the principle leader of the study of establishing the National Biotechnology Incubator for King Abdulaziz City for Science and Technology (KACST).
Dr. Wael Kaawach completed his Bachelor of Medical Biology with First Class Honors followed by his Medical Degree at The University of Aberdeen in Scotland. Dr. Kaawach then finished his residency and fellowship at the Harvard University Orthopedic Surgery Program. After which he joined The Harvard Medical School Faculty as an Instructor and Consultant in Orthopedic Surgery, and later appointed as the Chief of Orthopaedic Surgery at the Boston VA Healthcare System. He earned a Commendation Award from the US Department of Veteran Affairs and has multiple publications in peer-reviewed journals.
While in Boston, he managed to obtain an MBA in Healthcare Management; during which and upon his return to Jeddah, he was a cofounder, Board Member and Chief Medical Officer of the International Medical Center (IMC). He was instrumental in many aspects of the IMC's development, partnerships and staff recruitment.
Currently, he is the CEO of The Healthcare Development Holding Company (HDH), the healthcare arm of the Saudi Binladen Group. Since the inception of HDH in 2008, he has developed eleven subsidiary companies and five international affiliations that are specialized in various healthcare focused businesses with projects in Saudi Arabia and the region. It also has an affiliation with Cleveland Clinic Foundation, Ohio, USA (CCF) that resulted in the first Cleveland Clinic Global Solutions (CCGS) office in Riyadh, Saudi Arabia.
Dr. Khalid Al-Rubeaan, F.R.C.P. (C) is working as a Consultant Endocrinologist and Associate Professor, College of Medicine at King Saud University. He is also the Executive Director of Strategic Center for Diabetes Research, Editor-in-Chief of International Journal of Diabetes Mellitus Scientific Journal and Al-Sukari Magazine for Patient Education in the Middle East and the Head of the Saudi National Diabetes Registry. Dr. Al-Rubeaan is a member of many Diabetes Associations and Federations and had numerous publications in the form of chapters and books or scientific papers covering many fields of diabetes.
He was awarded the Arabian Award for Diabetes Education by the Pan-Arab Society for Diabetes and Endocrinology in 2001. He was also awarded the Novo Nordisk Research Merit Award in diabetes in 2002. He has obtained patent in the field of nano and IT technology in the area of diabetes management.
Dr. Majid Altuwaijri received his executive management training from Harvard Business School in 2012 and his PhD in Computer Engineering from the
University of Louisiana at Lafayette in 1995. Prior to joining Accenture in 2013, Dr. Altuwaijri was the CIO of the Saudi National Guard Health Affairs
for 17 years where his leadership led to the 2010 Middle East excellence Award in Electronic Health.
On the national level, Dr. Altuwaijri's chaired the national committee for e-Health in 2002 and then led the establishment of the Saudi Association for Health Informatics in 2006 and chaired four Saudi e-Health conferences.
On the academic level, Dr. Altuwaijri is an active researcher in the Health IT field with more than 30 publications and patents in top journals and conferences and holds a full professor academic rank at King Saud Health University where he established the MS Program in Health Informatics in 2006, the first of its kind in the Middle East. In 2007, Dr. Altuwaijri led the establishment of the college of public health and health informatics and was appointed the dean of the college. In 2010, he was appointed the University VP for technology and informatics.
For all his efforts and initiatives, Dr. Altuwaijri received the highest national medal from the King of Saudi Arabia in recognition of hisachievements in 2008.
Dr. Quinlan joined Ochsner in 1998 as Chief Medical Officer of Ochsner
Clinic Foundation. He served as Chief Executive Officer of the Ochsner
Clinic from 1999-2001 and then as Chief Executive Officer of Ochsner Health
System from 2001-2012.
Dr. Quinlan is currently the Chief Executive Officer of Ochsner Clinic Foundation and Ochsner International Services and the Executive Director of the Ochsner Center for Wellness and Health Policy. He is on the Ochsner Board of Directors, serves as Chair of the Medical Advisory Committee, and is a member of the St. Anne and the Ochsner West Bank Boards.
Before joining the Foundation, Dr. Quinlan served as Chief Medical Officer of Lovelace Health Systems in Albuquerque, New Mexico. He earned his Bachelor of Arts degree in Economics magna cum laude from the University of Texas at Austin and received his medical degree from the University of Texas Medical Branch at Galveston. Dr. Quinlan completed his dermatology residency at the University of Alabama at Birmingham and is Board Certified in Dermatology. He earned a Masters degree in Health Administration from the College of St. Francis in Albuquerque, New Mexico.
In May 2007, Dr. Quinlan was named the #1 most powerful physician executive in the nation by Modern Physician magazine. In 2008, he was selected as one of the "100 Most Powerful People in Healthcare" by Modern Healthcare magazine. Quinlan was also voted a Healthcare Hero in May 2007 by New Orleans CityBusiness Magazine. Ochsner’s Leadership Team also received the National Top Leadership award in 2006 from HealthLeaders Magazine
He currently serves on the Board of the Pan American Life Insurance Group, the Health Care Solutions Committee of the U.S. Chamber of Commerce, the Advisory Board of Iberia Bank and the Community Board for Café Reconcile.
Dr. Al-Buhairan has over 15 years of global professional IT experience
primarily within the health care industry (providers and payers). His experience
spans across transformational and enterprise-wide administrative, financial and
clinical/health information systems developments and implementations. He started
his career in the field of information systems and technology as a business and
systems analyst, and then moved on to enterprise-wide program and project
management, from where he then moved on to consulting.
His information systems consulting and program/project management portfolio includes: health information exchanges (HIEs), health insurers information systems, persuasive technologies, healthcare social media, mHealth, business process management (BPM) systems, enterprise data reporting (EDR) systems, human resources management systems (HRMS), enterprise resource planning (ERP) systems, customer relationship management (CRM) systems, referral process management systems, laboratory information systems (LIS), electronic health records (EHR), personal health records (PHR), radiology information systems (RIS), picture archiving and communication systems (PACS), and clinical information management systems (CIMS).
Academically, Dr. Al-Buhairan obtained his PhD in Health Information Systems and Technologies (Claremont Graduate University – USA), and has 2 Masters degrees; one in the field of Information Studies (University of Toronto - Canada), and the other in Information Systems and Technology (Claremont Graduate University - USA). Dr. Al-Buhairan's PhD course work was primarily focused on the domains of IT Management/Strategy and Health Informatics/Information Management. His research on the other hand, was focused across the domains of persuasive technologies, disability informatics, and health informatics.
Dr. Amal Al Seraihy obtained her degree in Medicine from the King AbdulAziz
University, Jeddah, and undertook a 4 year residency program at King Faisal
Specialist Hospital (KFSHRC - Riyadh). She then enrolled in a residency program
in Pediatrics at Texas Children’s Hospital and Baylor College of Medicine in
Texas. She was Fellow in Pediatric Hematology/Oncology at Duke University
Medical Center between 2000 and 2003.
She is board certified in Pediatrics and Pediatric Hematology/Oncology. Since 2003, she has been a Consultant in Pediatric Hematology/Oncology at KFSHRC (Gen. Org.)-Riyadh and is currently holding a position of Section Head, Pediatric Hematopoietic Stem Cell Transplantation and is Chair of the Stem Cell Transplantation Quality Management Committee.
She has written a number of book chapters and has co-authored some 30 articles and numerous conference abstracts and leads a number of investigational projects at KFSHRC (Gen. Org.) in the field of Pediatric Hematopoietic Stem Cell Transplantation.
Mr. Christopher Damon, JD, has been Executive Director of American
Medical Technologists (AMT) since June, 2000. AMT, founded in 1939, is a
certification organization for allied health professionals, especially
medical laboratory technologists, phlebotomists, dental assistants and
medical assistants. It currently has over 66,000 active certified healthcare
professionals world-wide. All of AMT's exam-based credentialing programs are
accredited by the National Commission on Certifying Agencies (NCCA).
He came to AMT with long experience in professional and management positions at national healthcare membership and accreditation associations including the American Medical Association, the American Hospital Association, and the Accreditation Association for Ambulatory Health Care. Mr. Damon was elected to two terms of service on the Board of Directors of the Institute for Credentialing Excellence (ICE), serving from 2002-2008.
Mr. Damon earned his Bachelor of Arts degree from Beloit College, and his Masters and Law degrees from the University of Wisconsin.
Prof. Tawfik Khoja is a fellow of the Royal College of General
Practitioners – UK (FRCGP-1989); a fellow of the Faculty of Public Health
(FFPH-2003); and a fellow of the Royal College of Physician – UK
He was awarded in June, 2003, the professorialship in health systems and quality (Adjunct Professor) from Oklahoma University, USA. At the beginning of 2010 he received the professorial degree from Imperial College, London, UK. He is a WHO temporary advisor.
Prof. Khoja works in family and community medicine and is a public health consultant. Other job responsibilities include overall development and implementation of PHC programs; conducting and coordination of field studies and research in healthcare system development; quality, patient safety; management and organization as well as in PHC.
He was the author and co-author of more than forty books and manuals. He has published more than seventy research and scientific articles in various international scientific journals which contributed in depicting health policies and work protocols in family medicine, PHC, Public Health, health systems, and health services quality. He has been awarded many local, regional and international awards and recognitions and is a member of many reputable scientific societies.
Dr. Philip D. Anderson, MD, FACEPis an Assistant Professor of Emergency
Medicine at the Harvard Medical School and the Director of International
Collaborations for the Department of Emergency Medicine at the Brigham and
Women’s Hospital (BWH) in Boston. He also serves as a Program Director for the
Fellowship Program in Emergency Department(ED) Leadership and Management at BWH.
Previously, he served as Associate Director of Quality Assurance in the
Department of Emergency Medicine at the Beth Israel Deaconess Medical Center.
Dr. Anderson is a Co-Founderand Program Director of the International Emergency Department Leadership Institute (IEDLI), based at the BWH. IEDLI has provided ED leadership and management training to hundreds of emergency department leaders from over 25 countries. He is a frequent lecturer at international emergency medicine scientific conferences on topics related to ED operations and management.
His research interests include emergency care delivery systems development, quality assurance metrics and development of informatics tools for emergency department quality measurement and performance monitoring. Dr. Anderson has published over 30 original articles, reviews, chapters and books on Emergency Medicine topics. His most recent textbook, “Emergency Department Leadership and Management: Best Principles and Practice” was published by Cambridge University Press in 2015.
He has advised governmental organizations, academic and private healthcare institutions on the development and optimization of emergency care delivery systems in over a dozen countries including Denmark, Iceland, Sweden, Italy, Honduras, Panama, Armenia, Turkey, the United Arab Emirates. He has also served as an advisor to theUnited Nations Disaster Management Training Program and theWorld Health Organization.
Mr. Khush Choksy is vice president for Turkey, Middle East, and North Africa Affairs at the U.S. Chamber of Commerce, where he leads the activities of the department in developing and implementing policies and programs to promote U.S. trade and investment with markets in the region. Choksy manages a team of program and policy experts focused on working closely with Chamber member companies and business and government leaders to advance and broaden commercial relationships between the United States and the region. In addition, he serves as executive director of the U.S.-Egypt Business Council and the U.S.-Bahrain Business Council. He is actively involved in the Chamber’s efforts to lead a Middle East Commercial Dialogue to foster intra-regional trade and investment.
Before joining the Chamber, Choksy was a director at Chemonics International where he led teams in developing economic ties between the United States and the Middle East. He lived and worked in Jordan for seven years, establishing relations with private- and public-sector leaders at a critical time in the U.S.-Middle East relationship on behalf of several USAID programs. He also worked in India, overseeing U.S. government and World Bank-funded projects that helped liberalize the capital markets and financial sectors.
His thought leadership includes presentations at international forums on business reform and U.S. trade and financial sector investment in emerging markets.
Choksy received his M.B.A. in strategic management from the Wharton School of the University of Pennsylvania and his B.A. magna cum laude from Hamilton College. He lives with his wife and daughter in Chevy Chase, Maryland.
Mr. Steve Lutes is Director of Middle East and North Africa Affairs at the U.S. Chamber of Commerce. He is specifically responsible for managing the U.S.-Iraq Business Initiative and serves as its director. In this capacity, Mr. Lutes is responsible for developing and implementing policies and programs that promote U.S. business opportunities and investment in Iraq. He works closely with Chamber member companies and business and government leaders to advance and broaden commercial relationships between the United States and Iraq.
Prior to his current position, Mr. Lutes was the director of the Chamber's Corporate Leadership Advisory Council. He was responsible for overseeing the council which serves as a platform for midmarket business executives to share input on a range of policy issues and shape the Chamber's probusiness agenda. Mr. Lutes also successfully led the Government Withholding Relief Coalition to repeal the onerous 3% withholding tax.
Mr. Lutes came to the Chamber from the U.S. Department of Commerce's International Trade Administration (ITA) where he was a senior legislative affairs specialist in the Office of Legislative and Intergovernmental Affairs. He focused on educating members of Congress on the benefits of trade and foreign direct investment and on advancing the Administration's trade agenda on Capitol Hill, including securing passage of the United StatesDominican Republic-Central America Free Trade Agreement (CAFTA).
Mr. Lutes also served as the congressional liaison to the President's Export Council and the Manufacturing Council for the Department. Previously, Mr. Lutes worked for the Republican Party in Columbus, Ohio, where he worked in conjunction with the Bush-Cheney reelection effort in Ohio through 2004, successfully directing political and grassroots strategy in central Ohio and helping turnout the largest county vote for former President George W. Bush in Ohio.
Earlier in his career, he worked on Capitol Hill for both Representative Ed Pease (R-IN) and Representative Brian Kerns (R-IN). He held a variety of positions, including press secretary, legislative director, and chief of staff. Mr. Lutes earned his bachelor's degree in marketing from Indiana University's Kelley School of Business. He is currently pursuing a Masters in Public and International Affairs from Virginia Tech.
Paula Wilson is President and Chief Executive Officer of Joint Commission Resources (JCR) and its international division, Joint Commission International (JCI). JCR and JCI are not-for-profit organizations working to improve health care quality and patient safety in nearly 90 countries around the world. JCI is leading health care improvement worldwide through its work with The Joint Commission as a WHO Collaborating Centre for Patient Safety Solutions, through development of international standards for quality and safety and international patient safety goals, and by offering domestic and international consulting, international accreditation, education, publications, Continuous Service Readiness, and e-Learning.
Ms. Wilson has more than 30 years of experience in the health care industry. Most recently, she provided management and strategic planning expertise as a consultant to public, nonprofit and private organizations. She was previously the vice president for policy at the United Hospital Fund, leading efforts to shape public policy changes related to insurance coverage, health care financing and Medicaid. Early in her distinguished career, Ms. Wilson served in several senior positions in the administration of New York Governor Mario Cuomo, including the executive deputy commissioner of the New York State Department of Health, and was responsible for all operational and management activities of a $1.2 billion organization with 7,000 employees. She also served as deputy director of the New York Division of the Budget, and as a program associate for Health and Human Services on the governor's staff.
Ms. Wilson taught courses in financial management and public and nonprofit administration at Columbia University School of International and Public Affairs, and graduate courses in health care financial management and corporate compliance at the Wagner School of Public Service at New York University.
Ms. Wilson received her master's degree in social work from the State University of New York at Albany. She is a member of the Board of the New York City Health and Hospitals Corporation and serves on the finance committee of the Saint Mary's Center, Inc., a nursing home for people with AIDS.
Mr. Rabih Torbay oversees International Medical Corps' global programs in some 31 countries on 4 continents and its staff and volunteers numbering in the thousands. Mr. Torbay has personally supervised the expansion of International Medical Corps' humanitarian and development programs into some of the world's toughest working environments, including Sierra Leone, Iraq, Darfur, Liberia, Lebanon, Pakistan, Afghanistan, Haiti, Libya and, most recently, Syria.
As the organization's senior representative in Washington DC., he serves as International Medical Corps' liaison with the U.S. government, including USAID, the Department of State, the Department of Defense, and the Department of Health and Human Services. Raised in Lebanon, Mr. Torbay is a civil engineer who worked in that field until early 1999, when he joined International Medical Corps' humanitarian efforts in Sierra Leone. Following the September 11 terrorist attacks, Mr. Torbay first went to Pakistan, and then Afghanistan, to lead International Medical Corps' emergency regional response team. He remained in Afghanistan for 8 months establishing programs throughout the country.
In October 2002, Mr. Torbay moved to International Medical Corps' headquarters in Los Angeles where he became Vice President of International Operations. In 2003, he led International Medical Corps into Iraq as the first non-governmental organization (NGO) to enter the country, and later one of the first NGOs to enter Baghdad after the war. He remained in Iraq for seven months, setting up a comprehensive relief and development initiative.
Mr. Torbay led International Medical Corps' rapid response team in 2004 into the Darfur region of Sudan, where its programs currently address the needs of more than 230,000 displaced persons in some of Darfur's most desolated areas. In July, 2006, after war broke out in Lebanon, Mr. Torbay organized International Medical Corps' emergency relief efforts to residents of the southern part of the country, who had been trapped in the fighting there.
After the devastating January 12, 2010 Haiti earthquake, Mr. Torbay organized and deployed International Medical Corps' Emergency Response Team that was on the ground in Port-au-Prince providing services in 22 hours. Similarly, he managed and closely supervised International Medical Corps' Emergency Response in Japan after the 2011 earthquake and tsunami; India after the 2013 cyclone; and, most recently in the Philippines after Typhoon Haiyan. Since 2011, Mr. Torbay has been overseeing the crisis in Syria and managing International Medical Corps' relief services for Syrian refugees.
Currently, he is supervising the organization's emergency response in Central African Republic and South Sudan after the recent outbreaks of conflict in both countries. Mr. Torbay oversees International Medical Corps' Ebola response in Sierra Leone and Liberia, where International Medical Corps is providing treatment to EVD patients through Ebola Treatment Units. Mr. Torbay currently lives in Washington, DC, with his family.
Mr. Hicks qualified as a surveyor in 1981 and became a partner in 1992 of Davis Langdon, a 7,000 strong professional services firm. Initially Mr. Hicks project managed a program of independent hospitals for BUPA across the UK. After spending time in the USA working for an architect-engineer on life science projects, he returned to the UK to run the multi US billion dollar GlaxoSmithKline research campus.
In between commissions for commercial and residential clients, Mr. Hicks developed a hotels and resorts speciality and over the last period has formed AECOM's multi-disciplinary Government & Public Sector offer, before becoming Managing Director of AECOM's program, cost & consultancy group. Mr. Hicks has also worked in the UAE, as well as projects across the world and helped establish the practice's P3 offer internationally.
Mr. Hicks currently leads on healthcare and science for AECOM with particular focus on the EMEA region. Within his practice group, keynote projects include the world's largest independent hospital, The Cleveland Clinic in Abu Dhabi; an all AECOM designed 1500 bed hospital in Saudi Arabia, The King Khalid Medical City. Recent Far East successes include Singapore's Sengkeng Community Hospital and the project management of two public hospitals in Hong Kong as part of their re-provision programme across the region. His team has just been appointed to undertake commercial management for the 600 bed Hillerod Hospital in Denmark. The group remains active in the UK primary healthcare NHS market and in its work for Nuffield Health, as well as for The Pirbright Institute where the world's leading Institute for Animal Health has its second major building program.
At the governmental level, Mr. Hicks sits on the Professional and Business Services Council at the UK's Department for Business Innovation & Skills, a committee jointly chaired by Michael Fallon, Minister of State and whose remit is to advise Government around matters affecting professional service firms. He is also a design panel member on both the World Architectural Networks and the International Academy for Design & Health.
Mr. Hicks refreshed his business skills through Harvard's managing professional business firm program. He has an ability to view problems from a client's perspective and through his experience and leadership provides excellent client service. His strategic and commercial thinking and tactical application are useful skill sets in the firm's senior leadership team.
Claes Johansson has over 30 years' experience in hospitals working on international hospital D&B projects in Europe, the Middle East and Asia. He has a unique understanding about the way hospitals work and function and the complex needs of hospital staff and managers. This knowledge is essential for projects to be successful.
Mr. Johansson has held a wide range of senior positions from medical equipment planning and procurement through to design and project management. He holds an Executive MBA from Lund University and a certification in International Project Management and Organization from Linköping University.
Before joining AECOM, he led the winning Skanska Bid team for the new Karolinska University Hospital in Stockholm. At $2.2bn this is the largest ever healthcare project constructed under a PPP agreement. Once the bid was won, Mr. Johansson became the Design Director for the project company working on the scheme for four years.
Professor Ghassan Abou-Alfa joined Memorial Sloan Kettering Cancer Center in 2001. He has specialized in treating patients who have primary liver cancer. Professor Abou-Alfa is the Chair of the National Cancer Institute Hepatobiliary Task Force. His work focus on investigating and testing novel targeted therapies in clinical studies and advocates for greater awareness of the disease's global impact. He majored in biology at the American University in Beirut (AUB) and earned his medical degree there as well. In 1992, he joined the Yale School of Medicine for postdoctoral training.
Professor Abou-Alfa completed his fellowship and joined the Yale faculty in 2000. At Memorial Sloan-Kettering he started focusing on primary liver cancer — cancer originating in the liver. Liver cancer affects a diverse population from many cultures and economic backgrounds and is truly a global disease. It is one of the top five cancers worldwide, and mainly affects people in sub-Saharan Africa and Southeast Asia, where hepatitis B, a major risk factor, is endemic. The disease has its impact on Egypt and parts of the Gulf as well. While it is not common in the United States, its incidence is increasing due to the silent epidemic of hepatitis C virus witnessed in the last few decades, the rise in the number of people with morbid obesity and diabetes, and the persistence of alcoholic cirrhosis — all risk factors.
Professor Abou-Alfa has taken on an advocacy role because research funding has lagged despite the worldwide impact of this disease. Liver cancer does not have a public-figure spokesperson raising awareness, and there is not much knowledge about it among patients and the public. One step he took to address this was co-authoring, with Memorial Sloan Kettering Cancer Center hepatobiliary surgeon Ronald DeMatteo, a book in lay language called 100 Questions and Answers About Liver Cancer, now in its third edition. Dr Abou-Alfa also co-authored a similar book in Arabic with Dr Ashraf Omar from University of Cairo, that is awaiting to be published.
Professor Abou-Alfa is a major contributor to the field's research. His research focus is on incorporating small biological molecules into standard cancer therapies. In recent years, his group at Memorial Sloan-Kettering Cancer Center led the initial efforts evaluating sorafenib (Nexavar®) in primary liver cancer. Sorefenib was ultimately approved by the FDA for that indication in 2007. In a trial also led by his group at Memorial Sloan Kettering Cancer Center, they are now investigating whether combining sorafenib with the standard chemotherapy drug doxorubicin produces an improved outcome. As an institution, they are proud to be the leaders of this first national effort of a large clinical trial in primary liver cancer, which is supported by the National Cancer Institute. Professor Abou-Alfa continues to lead several international efforts and is involved in conducting clinical trials with colleagues around the world, especially in Southeast Asia, which helps to understand the challenges of managing a disease with varying risk factors, in different regions of the world.
Professor Abou-Alfa has also spearheaded many projects in the Arab World since 2006 under the auspices of the Elmer and Mamdouha El-Sayed Bobst International Center, now headed by former Chair of Memorial Sloan-Kettering's Department of Surgery Sir Murray Brennan. Under the direction of Professor Abou-Alfa, Memorial Sloan Kettering Cancer Center has established a strong relationship with American University of Beirut, with an ongoing faculty exchange and a monthly video-link conferencing with the AUB physicians, with several of its proceedings are already published in peer–reviewed journals. The Memorial Sloan Kettering Cancer Center faculty teaches about the state of the art of cancer care in the US and the AUB faculty teaches about the risk factors and treatment practices in their country. This joint collaboration, one of the most sustained between an US institution and one in the Middle East, has led to the development of the first joint tissue bank with a shared database in the region. Memorial Sloan Kettering Cancer Center and AUB have also joined efforts on a first in its class training course for oncologists in the Arab World, that is offered on competitive basis and has already featured in Beirut, Doha, and is anticipate to take place in Kuwait City in October 2015. The joint program also offers supported fellowship opportunities for excelling medical graduates.
Dr. Samar Alsaggaf has served as academic lecturer and physician with a specialization in anatomy, embryology, histology, and a particular expertise in the development of the nervous system. Moreover, Dr. Alsaggaf is a recipient of a Doctorate of Humane Letters from Saint Joseph University and has been voted as one of the most influential leaders. She is also a recipient of the International Dental Education Award from New York University. During the course of her tenure, Dr. Alsaggaf has been named, “The Mother of Saudi Students,” by Saudi students in the United States. She is also a recipient of many awards from the Kingdom of Saudi Arabia and the United States. In her current position at SACM, she was voted as best director of the year in 2011 and 2012.
Dr. Nick van Terheyden brings a distinctive blend of medical practitioner and business strategist, both national and international, to the realm of healthcare technology. A graduate of the Royal Free Hospital School of Medicine, University of London, Dr. van Terheyden is a pioneering creator in the evolution of healthcare technology. After several years as a medical practitioner in London and Australia, he joined an international who's who in healthcare, academia and business, in the development of the first electronic medical record in the early 1990's and later, as a business leader in one of the first speech recognition Internet companies.
His rare combination of patience, creativity, skill and intrinsic business ethics has led him to a diverse career in healthcare with some of the most prestigious hospitals,consulting firms, and technology companies. He is currently Chief Medical Information Officer – Clinical Language Understanding for Nuance Communications where his insider perspective allows him to put his medical and technology expertise to work for clients who are striving to raise the bar for healthcare delivery. He is a member of the HIMSS Health Committee where he pays attention not just to processes and systems, but to people. He ofter speaks on the practical and futuristic use of healthcare technology and how it can cost effectively improve patient care.
In addition to writing and lecturing on futuristic trends in healthcare technology, his advice and counsel is sought by hospitals, physicians and other allied healthcare professionals -- all of whom are exploring how to integrate and use technology to make the healthcare system work from the perspectives of quality and financial success.
Dr. Ali Saeed Alzahrani currently serves in three professional roles: Consultant Endocrinologist, Department of Medicine as well as Scientist and Head, Molecular Endocrinology Section, Department of Molecular Oncology, Research Centre, King Faisal Specialist Hospital & Research Centre, and finally as Professor of Medicine and Endocrinology, AlFaisal University, Riyadh, Saudi Arabia.
He was an editorial board member for the Annals of Saudi Medicine from 2003 to 2007 and went on to be editor-in-chief for the same journal from 2007 to 2010. He is now an international member of the editorial board of the British Journal of Diabetes and Vascular Diseases. Dr. Alzahrani has produced 65 peer-reviewed articles, has delivered over 90 lectures in Saudi Arabia and internationally and has made more than 80 national and international poster and oral presentations at conferences.
Mr. Jeremy T. Bonfini is Executive Vice President, Global Services, for HIMSS, the largest U.S. cause-based, not-for-profit healthcare association focused on the optimal use of information technology and management systems for the betterment of healthcare.
Mr. Bonfini is responsible for the development of the Society's programs outside of North America. During his tenure, he has grown HIMSS' international presence through the establishment of offices in Brussels and Singapore. Before joining HIMSS, he served as Intel Corporation's Worldwide Digital Health Policy Manager. In this role, he contributed to European Union developments on eHealth interoperability, facilitated advancement of a national EHR Standard in the People's Republic of China and supported approval for medical devices using WLAN/Bluetooth in Japan.
Earlier in his career, Mr. Bonfini served as an Education Policy Analyst in the House of Commons in London, England. Upon returning to the United States, he represented the National Mining Association in Washington, DC, and worked with the U.S Representative from Ohio's 18th Congressional District to provide constituent services and advocated for legislation favoring economic development.
He is a magna cum laude graduate of The American University, Washington DC, with a Bachelors degree in Political Science and a member of the Phi Beta Kappa Society.
Dr. Hassan El Solh MD, FAAP, FRCP is Professor of Pediatrics and
Director of the Children's Cancer Center of Lebanon. He is
certified by the American Board of Pediatrics and Pediatric
Hematology Oncology, and by the Royal College of Physicians and
Surgeons of Canada.
Dr. El Solh graduated with the degree of Doctor of Medicine from AUB in 1980, after which he completed his residency training in Pediatrics at AUBMC (1980-1983); followed by two years of residency in Pediatrics at the University of Western Ontario, Canada (1983-1984 and 1986-1987); two years of fellowship in Pediatric Hematology Oncology at the University of Toronto, The Hospital of Sick Children (1984-1986); and, one year of Clinical Fellowship in Bone Marrow Transplantation at the Fred Hutchinson Cancer Research Center at University of Washington (1987-1988). Dr. El Solh was appointed as Assistant Professor at the University of Toronto (1988-1992); as Associate Professor at AUB (August 1996 - February 1997); and, as Professor at Al Faisal University, KSA in 1997.
Over the years, Dr. El Solh has an illustrious career in Pediatric Oncology & Bone Marrow Transplantation and has assumed numerous appointments and responsibilities. He has served as Associate Director, Bone Marrow Transplant Program and Director of Autologous Bone Marrow Transplant Program at the Hospital for Sick Children, Toronto, Canada (1988-1992); Deputy Medical Director and Director of Bone Marrow and Stem Cell Processing Program at the Canadian Blood Center, Toronto, Canada (1989-1992); Director of Pediatric Bone Marrow Transplantation Program and Consultant Pediatric Hematology-Oncology (1992–1996); Head Section of Pediatric Hematology/Oncology (1998–2000); Chairman of the Department of Pediatric Hematology/Oncology (2000-2006); Assistant Deputy Chief Operating Officer and Medical and Clinical Operations (2001-2005) at King Faisal Specialist Hospital and Research Centre; Medical Director (2000-2008) at King Fahad National Center for Children's Cancer& Research; Deputy Executive Director (2005–2008) at Medical and Clinical Operations at King Faisal Specialist Hospital & Research Center; Executive Director (2008-2011) at King Fahad National Center for Children's Cancer; Executive Champion of Strategic Project: Establish and Develop World leading of Programs/ Services for KFSH&RC (2009–Present); Senior Consultant of Pediatric Hematology/Oncology at the Department of Pediatric Hematology/Oncology (2011–Present); and Executive Management Consultant International Collaboration and Development at the General Corporate Consultancy Office of King Faisal Specialist Hospital & Research Center- General Organization (2011-Present).
Dr. El Solh name appears on 76 journal publications; 37 as first/ senior author and 5 as second author. He has 55 original articles, 18 case reports, 3 letters and 1 review. Of the 37 publications as senior author, Dr. El Solh has 6 articles (2 original & 4 case reports) in refereed journals that are in the upper 25th percentile; and, 13 articles (11 original, 1 letter & 1 case report) in journals that rank between 50-75th percentile in their respective disciplines with respect to impact factor.
Dr. Fadi Bitar is the Associate Dean for External Medical Affairs, the
Director of the Children's Heart Center, and the Co-Director of the Congenital
Heart Disease Genetics Research Program at the American University of Beirut. He
is a Professor of Pediatrics, Biochemistry and Molecular Genetics. Dr. Bitar is
certified by the American Board of Pediatrics and the Sub- Board of Pediatric
Dr. Bitar is also the Co-Founder of the "Brave Heart Fund", a charitable fundraising initiative established to provide financial and humanitarian assistance to needy families suffering from Congenital Heart Disease (CHD). The Brave Heart Fund helped to provide care for more than 2700 children with CHD, since its inception in 2003.
Dr. Bitar earns worldwide recognition as one of the leading Pediatric Cardiologists in Lebanon, the region and beyond, and has major contributions which include the successful establishment of new clinical programs resulting in improvements towards the care of thousands of children with CHD. Dr. Bitar introduced new modalities and techniques for medical and catheter treatment of heart disease, including procedures that were first of their kind in the world. Dr. Bitar is the recipient of several awards , including the Humanitarian Recognition Award for "Service Above Self" presented by "Rotary International Clubs and Gift of life project" in USA and he is a member of Alpha Omega Alpha Honor Medical Society.
Dr. Bitar pioneered innovative research in the field of Pediatric Cardiology. His basic research interests include genetics of CHD and mechanisms of myocardial growth in the chronically hypoxic heart. Dr. Bitar reported worldwide discoveries of novel genes responsible for CHD. He also developed an animal model of chronic hypoxemia, mimicking cyanotic congenital heart disease. Dr. Bitar established the Children's Cardiac Registry Center in Lebanon and developed the first Pediatric Cardiology Fellowship Program in Lebanon. He organized and chaired several international meetings including among others, the "International PedCard Beirut 2012" and the "First Middle East Symposium in Pediatric Cardiology-Surgery".
Dr. Bitar, in his capacity as Associate Dean for External Medical Affairs, had spearheaded and coordinated numerous agreements between AUBMC/FM and national, regional and international medical schools/organizations/universities in Lebanon, Syria, Iraq, Jordan, UAE, Saudi Arabia, Palestine, Kuwait, Bahrain, Europe and the United States.
Dr. Bitar has published more than 150 articles, book chapters and abstracts. He organized, moderated, chaired, and was an invited speaker to more than 120 national and international conferences. He is a member of the Editorial Board and a reviewer for numerous international medical Journals. Dr. Bitar supervised and co-advised more than 50 master theses, postdoctoral fellows and research physicians. He has been the recipient of more than 30 national and international research grants, including the Dubai-Harvard Foundation Research Grant.
Dr. Hanna is an Associate Director at the Duke Cancer Institute, surgical and imaging facility which leads translation medicine and drug development to clinical work, foster innovations design and conduct preclinical researches translational to clinic and patient care. Collaborate and work with Biotech and pharmaceutical industry to conduct preclinical and translation research at Duke, including: Clinical trial; GLP good laboratory practice; IND new drugs development; IDE and medical device development; novel imaging methods.
Dr. Hanna worked with GlaxoSmithKline pharmaceutical on antiangiogenic therapy project. He led the multidisciplinary team at Duke to develop new treatment protocol based the tumor oxygenation after evaluation the different antiangiogenic therapies on cancer prognosis; microenvironment; vascular; drug delivery; EMT; VGF; PDGF.
Dr. Hanna is also the President, Chairman of North Carolina Society of Physician Entrepreneurs. As serial entrepreneurs, Dr. Hanna took the role to be the president and chairman for the professional society dedicated to advancing healthcare innovation. By linking clinicians, entrepreneurs, technologists, investors, VC/ PE, universities, industries and policymakers with creative business strategy to create next generation of technology to get to the new area of medical practice.
Dr. Hanna newest technology start-up is AMERICAN REMOTE HEALTH and TeleCancer. It is the first and only Telemedicine service and app that focuses on cancer and chronic diseases to improves the outcome care. By utilizing telecommunication technology, it helps extend the medical advanced knowledge and research of academia centers and top universities like Duke, Mayo Clinic, Cleveland Clinic, NIH, Harvard, etc. beyond the wall of universities.Patients have the option to upload their complete medical records (via HIPPA compliant apps or EMR web system) and communicate to the top 2% of doctors in US. American Remote Health doctors will provide a written treatment plan including genetic personalized treatment and clinical trials; collaborate on the treatment with the local doctors; or arrange the treatment and logistic for patients to come to the best hospital to receive the treatment/ surgery upon the next day of their arrival. American Remote Health is not just saving lives and improving outcome but eliminating unnecessary surgeries, and possibly "wrong" treatments.
Dr. Hanna graduated medical school from Aleppo, surgical internship acting at University of Texas Medical Branch and his Radiation Oncology postdoctoral fellowship at Duke University.
Dr. Osama Al-Swailem is the Consultant of Family Medicine and Corporate Chief Information Officer at King Faisal Specialist Hospital & Research Centre. Dr. Al-Swailem is also an Assistant Professor of Medical Informatics at Al-Faisal University.
He obtained his MBBS from Medical School, King Saud University, Riyadh, Saudi Arabia in 1991 and his Primary Healthcare Diploma from Medical School, King Saud University in 1994. Dr. Al-Swailem obtained his Arab Board Certification in Family Medicine in 1995. Dr. Al-Swailem has a Master Degree in Medical Informatics from Columbia University, USA in 1998 and a Post Doctoral Fellowship from Columbia University, USA in 1999.
Dr. Al-Swailem has over 17 years of working experience in the field of Medical Informatics and Information Technology in Healthcare. He is a board member of the Scientific Committee of the National Centre of Health Information, Council of Health Services. He is a member of Healthcare Information and Management Systems Society (HIMSS). He co-authored the book "Developing Data Warehouse for the Healthcare Enterprise-Lessons from the Trenches." His book was selected as the "book of the year" for 2008. He attended and presented several papers in various international and regional conferences and sysmposiums.
Dr. Tariq Ahmed Madani obtained his bachelor degree in Medicine and Surgery (MBBS) from the Faculty of Medicine at King Abdulaziz University Hospital, Jeddah, Saudi Arabia in 1988.
He was appointed as a faculty staff in the Department of Medicine in the same college in 1989. He completed training in Internal Medicine at the University of Ottawa, Canada, in 1993 and a fellowship in Infectious Diseases in the University of Manitoba, Canada in 1996. He obtained the Royal College of Physicians and Surgeons of Canada, and the American Boards of Internal Medicine in 1994 and in Infectious Diseases in 1996. He was subsequently appointed as Assistant Professor of Medicine and Infectious Diseases at the Faculty of Medicine, King Abdulaziz University, in 1996. He is currently a full professor of Medicine and Infectious Diseases.
From 2000 to 2007, he worked as a full time advisor to the Saudi Minister of Health and the Chairman of the National Infection Control Committee; the Ministry of Health Scientific Committee; Hajj Infection Control Committee; and, many other important national committees. He was a member of the Joint Coordinating Board (JCB) of the Special Program for Research and Training in Tropical Diseases (TDR), World Health Organization. He was awarded a letter of appreciation from the late King Fahd Bin Abdulaziz for making the diagnosis of Rift Valley Fever in Saudi Arabia and designing the strategy to control the epidemic. He also discovered a new viral hemorrhagic fever, referred to as Alkhumra viral hemorrahgic fever, in Makkah in 2001.
He has been appointed as a chairman of the "Viral Hemorrhagic Fever Scientific Chair" at King Abdulaziz University in October 2008 to lead basic and clinical research to study and explore this new virus. He was also elected as the Chairman of the Saudi Society of Internal Medicine in 2011. He was awarded Nawt Alhajj from His Royal Highness the Minister of Interior for Distinguished Contributions to the Health of Pilgrims in Hajj. He has extensive clinical experience in the management of infectious diseases and hospital and field infection control. He has many publications in the field of internal medicine and infectious diseases.
On April 25, 2014, he was appointed as an Advisor to His Excellency the Minister of Health, and the leading scientist to prevent and control the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Saudi Arabia, and Chairman of the Scientific Advisory Board of the Minister of Health.
Dr. Mohammed Basulaiman, MD, F.F.C.M., D.Q.M. is a family and community medicine consultant and a health facilities specialist in quality management.
Dr. Mohammed currently holds the position of Assistant Deputy Minister for Primary Health Care in Ministry of Health, Saudi Arabia. He obtained his M.B.B.S. degree in Medicine & Medical Sciences from King Faisal University in 1987; and, he received his Fellowship in Family & Community Medicine in 1993, and a diploma in Quality Management in Health Facilities in 1999.
Dr. Mohammed has held several positions including :
- Director general of Health planning Department, M.O.H.,S.A., 2006-2012.
- Director General of Primary Health Care Centers, M.O.H.,S.A., 2003-2006.
- Consultant for Council of Health Services, 2008 -2012.
- Coordinator of postgraduate studies in family medicine, M.O.H.
- Trainer in Al-Rabwah postgraduate family medicine training program, 1995-2006
- Medical Director of Dammam Central Hospital, 1993-1995.
Dr. Mohammed Basulaiman is a member of several professional organizations and committees. He has published a number of papers in national and international medical journals. He authored & co-authored 16 books and manuals in the field of primary healthcare and quality improvement. He has also participated in many scientific conferences and seminars, local, regional and international.
Dr. Mohammed was also the principal investigator and/or co-investigator of numerous health researches including the World Health Survey in Saudi Arabia; Survey of Health Information in S.A.; and, the National Elderly Health Survey in Saudi Arabia.
- KFU Fellowship of Family & Community Medicine in 2000.
- KFU Diploma in Family & Community Medicine in 1998.
- MBBC – King Abdul Aziz University, Faculty of Medicine and allied Sciences, In the Spring of 1991 – 1992, Jeddah, K.S.A.
- Diploma in Hospital Accreditation Surveyor. ( Oklahoma, U.S.A)
Positions, Employment and Honors
- Consultant of Family & Community Medicine in PHC – MOH.
- Member of National Committee for the Health of Adolescent & Yung.
- Ass. Professor College of Medicine KSU
- Temporary Adviser for (WHO) for Non-communicable & Other Programs.
- Leading researchers in the field of Non-Communicable Diseases; the last survey conducted was: The Saudi Health Information
- General Directorate for Control of Genetic and Chronic Diseases
- Coordinator of National committee of Cancer Prevention.
- Member of Gulf Committee for NCD Prevention.
- Survey for Non-Communicable Diseases 2013.
- Member of the Global Burden of Diseases Consultation Committee.
- Advisor at the Global Burden of Diseases.
- Hypertension & its associated risk factors in KSA 2013.
- Status of diabetes epidemic in KSA 2013.
- Hypercholesteremia and its associated risk factors in KSA 2013.
- Obesity and associated factors – KSA 2013.
- Fruit and vegetable consumption among adults in Saudi Arabia 2013.
- Behind the veil: progress and challenges for women’s health in Saudi Arabia.
Dr. Maha Almozaini is a researcher and scientist. She gained her experience in Immunology and Virology research during her PhD training at the Imperial College School of Medicine, London, UK, and during her post-doctoral research fellowship at the Infectious Disease Division of Massachusetts General Hospital, Harvard Medical School, Boston, USA.
She has already made a substantial contribution to the field of immunocompromised host research and, therefore, established an Immunocomprmised Host research (ICH) Division at King Faisal Specialist Hospital & Research Center (KFSH&RC).
Dr. Almozaini is dedicated to further developing the international collaboration of research that was initiated with MGH, Ragon and Harvard, on both HIV and transplant research. This strategic alliance offers a unique opportunity to perform parallel investigations on immune dysregulation and immune deficiency in patients from two different continents with different genetic background. This will initiate immunological and molecular research collaboration with a true global and international perspective. This cross-cultural contribution will help to better understand immune dysfunction and, as a result, will improve the life quality of patients living with immune deficiency in both countries.
Dr. Almozaini's research is funded by King Abdulaziz City for Science and Technology (KASCT). She is also in the initial steps into developing an HIV awareness programs making her one of the few investigators conducting HIV-1 related research in KSA. Her collaboration with MGH/HMS will allow further understanding of HIV-1 pathogenesis in the Middle East and Arabic Gulf region.
Dr. Essam AlGhamdi is a consultant family physician. He is also Chairman and a member of several MOH national committees.
Dr. Al-Qumaizi is the Dean of College of Medicine & General Supervisor of Medical Services, Al-Imam Mohammad Ibn Saud Islamic University since September 2012. He has obtained his Saudi & Arab Board of Family Medicine in 2001, during his residency training program selected as the Best Resident in Family & Community Medicine for 3 consecutive years 1997, 1998 & 1999. He was appointed as the Resident Co-coordinator for the Saudi Board Training Program Residents from 1997 up to 2000, CME Co-coordinator in the NCOHC from February 2002 up to March 2004, Member of Training Committee in F & C Medicine Department, RKH since September 2002 to Feb. 2009.
Dr. Al-Qumaizi worked as a Doctor in-Charge at Al Wazarat Health Centre, F & C Medicine Department (the main training centers in Family & Community Medicine and biggest centers in Riyadh Military Hospital with more than250 multi-nationality staff) from August 2004 till February 2009. He is Representative of the Ministry of Education (MOE) at the administrative board of National Unified Procurement Company for Medical Supplies (NUPCO).Representative of the college in different consultative committees the university counseling committee, the training and scholarship committee.
Currently, Dr. Al-Qumaizi is the Chairman of the College Board, Member of the University Board, Member of the Saudi Medical Deans’ Committee, and Member of the GCC Medical Deans’ Committee since September 2012. He worked as the vice dean for quality and development, as the vice dean for the administrative affairs, the college of medicine at Al Imam university from December 2009 up to April 2012.He is an assistant professor at the college of medicine, Al-Imam University from 2/2008.
Dr. Al-Qumaizi speaks in many conferences related to family medicine and published on topics related to obesity, medical education and Research Ethics.
Dr. Bandar Al Haqbani currently works as the General Director of IT Services at King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) and acts as an Information Security Advisor to National Guard Health Affairs. In addition, he is the Chairman, Health Informatics Department and Assistant Professor within the College of Public Health and Health Informatics of KSAU-HS where he teaches IT and information security courses. Also, he holds the position of President of Saudi Association for Health Informatics and Head, Advanced Computing and Technologies, King Abdullah International Medical Research Center.
He is a co-founder of the Health Information System Bachelor's program and has published number of scientific research papers in international journals and conferences. His research interests cover federated identity management, access control security, e-Health security and privacy, network applications and security and cyber warfare. Dr. Alhaqbani has conducted several information security seminars to many Saudi governmental agencies.
He started his career as a Network Specialist then shortly after he handled the Security Architect and was later appointed as Manager of IT Security and IT Planning within the National Guard Health Affairs. Shortly after, he was appointed Director of IT Planning Division at KSAU-HS.
He obtained a Bachelor's degree with top honors in Computer Engineering, a Master's in Information Technology with a specialization in e-Business and a Doctorate in Information Technology with a specialization in Information Security.
Dr. Sami Al Abdulkarim in 2000, earned a Master's Degree in dental implantation from the International Dental Implantation Association in
United States of America.
Working part-time at the Ministry of Health, he is responsible for licensing medical centers with specialized dental clinics. He also works at the Riyadh Dentistry Center and is Deputy Director of the Riyadh Dental Medical Complex Center. This has provided him with the education and experience to start his own business.
Dr. Sami Al Abdul Karim is now Chairman of the Board of Trustees of Inaya Medical College which provides education to the Bachelor level in the specialties of Clinical Laboratory Sciences, Biomedical Technology, Nuclear Medicine, Radiological Sciences, Dental Health Care, Respiratory Therapy, Emergency and Critical Care, and Medicine and Nursing.
Dr. Khalid Abdulmoshen Almeshari, MD, FACP is board certified by the American Board of Internal medicine. His past committee appointments include:
Renal Transplant Committee, KFSH&RC, 2001 - 2014
Former Chairman Medical Staff Credentials Committee, 2000 - 2004
- Al Babtain Kidney Centre Task Force
- Final Acceptance of the Medical Equipment for the New Hemodialysis Unit
- Hemodialysis Committee
- New Hemodialysis Unit Work Group
- Collaborative Practice Management in Hemodialysis Unit
- Patient Affairs Forum
Medical Advisory Council of Medical and Clinical Operations, 2000 - 2005
- Medical and Clinical Operations, Management Committee, 2000 - 2005
- Medical and Clinical Operations, Patients Complaint Committee 2000-2005
- Medical and Clinical Operations, Management Committee, 2000 - 2005
- Medical and Clinical Operations, Patients Complaint Committee 2000-2005
Clinical Research Committee of the Research Advisory Council
A board certified Emergency Physician with a Masters in Health Administration (MHA) and over 16 years of experience in Clinical Medicine, and more than 7 years in a leadership role in health administration, Performance Improvement, Quality Management & Patient safety, and public health in a leading healthcare organizations in Saudi Arabia. As a Physician I worked in different health care systems in variable clinical and administrative roles within Canada and Saudi Arabia from residency until now.
I am the Executive Director, Quality and Patient Safety Department in Ministry of National Guard Health Affairs, where I am responsible for providing the necessary leadership and support to ensure the effective delivery of high quality, safe health services for patients.
In my clinical role I am a consultant of emergency medicine in KAMC-Riyadh, with 99 beds and more than 200 thousands visits annually we are the largest emergency department is the country. The department is staffed with board certified emergency physicians, and host more than 70 residents enrolled in the Saudi board of emergency medicine.
I am also a Certified Professional Improvement advisor and hold the position of Director of the Quality Management Department, Ministry of National Guard Health Affairs (MNGHA) where I am responsible for the Accreditation activities of the MNGHA, Patient safety initiatives, facilitating all major process improvements projects.
Mr. Morgan Honea is the CEO for the Colorado Regional Health Information Organization (CORHIO), one of the nation’s largest and most successful public health information exchange (HIE) organizations. Prior to joining CORHIO, Mr. Honea served as the Chief Executive Officer of Plains Medical Center, a Federally Qualified Health Center with four locations in eastern Colorado. In his role, Mr. Honea was responsible for executive leadership of the organization that served over 9,500 patients through 40,000 visits annually. He helped lead the negotiations for Plains Medical Center’s merger with Peak Vista Community Health Centers, a Federally Qualified Health Center in the Colorado Springs area.
Mr. Honea received his Master’s in Health Administration from Missouri State University and his Bachelor’s Degree in Accounting from the University of Tulsa. He began his healthcare career in public health in Southwest Missouri before transitioning to the local Community Health Center. Through his various roles, Mr. Honea has championed healthcare services for the underserved, better integration of oral and behavioral health services with primary care, and the advancement of health information technology. Honea serves on the board of directors of both the Colorado Community Health Network and the Colorado Community Managed Care Network.
Ransel Potter has been a guest speaker at financial events in the Middle East and the United States. His contacts throughout the Middle East and the United States are with the top global financial institutions; high net worth families; and, government representatives, including several Sovereign Wealth Funds. He is currently licensed with a Series 7, Series 66 and Series 3.
The founder and Managing Director of COPARA, he continues to build a rewarding career spanning three decades, and multiple industries, including many noteworthy achievements. His abilities to lead, strategize, develop business and maintain relationships have all contributed to his success.
Mr. Potter founded C3 Summit LLC in 2010. The mission of C3 Summit is to ensure that both US and Arab businesses grow and prosper by providing unique and valuable commerce opportunities. By creating a global forum for both the US and the Arab world to explore private/public sector growth and employment generation, C3 Summit hopes to encourage each region to open new opportunities to enhance the welfare of freer trade and the exchange of knowledge transfer and best practices in both commerce and healthcare.
Prior to founding C3 Summit, Mr. Potter has been marketing financial instruments in the Middle East under the umbrella of Copara. He personally negotiated with Value Line the international distribution rights regarding both terms and conditions. In less than 11 months, Mr. Potter established several funds. One funded and managed by the National Bank of Abu Dhabi (the 50th strongest bank in the world). He also was successful in marketing a high yield fund for Thomson Reuters with the National Bank of Abu Dhabi. The other, The National Investor, a top boutique investment banking house located in Dubai. He was also responsible for engaging with the Abu Dhabi Investment Company (Invest AD) an assignment to incorporate a quantitative ranking system, with a $30 million GCC/MENA fund, managed by Invest AD.
Morgan Stanley recognized the value of Mr. Potter's experience and relationships and, in 2007, they invited him to join the firm. Until December of 2010, Mr. Potter served as a Senior Partner on their Private Wealth Management team responsible for identifying viable business opportunities among high net worth clients, families, hedge funds and foundations. His introductions had been a cornerstone of the team's success producing more than $250 million of net new assets in 36 months. In 1992, Mr. Potter founded Kinloch Marketing and occupied the role of CEO until 2007. Kinloch designed and brought to market sales lead generation and management systems for the Insurance, Banking and Energy industries. Kinloch's success was a direct result of his leadership and a network he established with senior executives of Fortune 1000 companies.
In 1990, his previous achievements were recognized by Flair Communications and he was asked to run their NY office. He merged R.N. Potter Associates with Flair's New York office and built that regional office in to the largest of their five domestic offices, leaving in 1992 to establish Kinloch Marketing. He formed R.N. Potter Associates in 1984, a marketing and sales organization, which he headed until 1989. During that time, Mr. Potter personally initiated, negotiated and developed one of the largest independent contracts for advertising billboards with the Penn Central Corporation.
In 1980, Mr. Potter, together with a partner, started On Line Media, an innovative supermarket ad company. Within three years, they took On Line Media public, raising capital and watching the stock soar. Upon selling his shares of On Line Media in 1984, he formed R.N. Potter Associates. Mr. Potter, a graduate of Syracuse University, has six children and, with his wife, lives in East Hampton, NY.